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Formation of the follicular fluid antrum within the ovarian follicle provides a unique 
environment for the developing oocyte.  Follicular fluid contains factors including 
nucleic acids, proteins, lipids, hormones, and metabolic factors secreted by both ovarian 
somatic cells and the oocyte that are critical for follicle development.  In addition, lipid 
bi-layer extracellular vesicles (EVs) comprised of exosomes and microvesicles are highly 
abundant in follicular fluid.  Whether these EVs play a role in ovarian cell signaling, 
provide a mechanism for transport of metabolic products or are nonfunctional within the 
ovarian follicle is unknown.  In this dissertation, I will test the hypothesis that ovarian 
follicular fluid EVs are unique and determine whether they can elicit functional effects on 
the cumulus-oocyte-complex and the mural granulosa cells.  To accomplish these goals, 
follicular fluid from three different sizes of bovine antral follicles, [i.e. small (3-5 mm), 
medium (6-9 mm), and large (>9 mm)] were collected and EVs were isolated and 
characterized by electron microscopy, nanoparticle tracking analysis (NTA), protein 
marker analysis, and small RNAseq.  Electron microscopy and NTA indicated the 
presence of a uniform (50-200 nm) population of EVs that had different microRNA 
within them based on follicle size. An EV marker, CD81, showed decreased abundance 
in EVs as follicle size increased.  Fluorescent labeling of the follicular fluid EVs 
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followed by culture indicated that both cumulus and mural granulosa cells took up the 
fluorescent-labeled EVs.  To test for functional activity, cumulus-oocyte-complexes and 
granulosa cells were exposed to EVs isolated from different size follicles.  Extracellular 
vesicle treatment caused expansion of cumulus cells and increased expression of 
prostaglandin-endoperoxide synthase 2 (Ptgs2), pentraxin-related protein 3 (Ptx3), and 
tumor necrosis factor, alpha-induced protein 6 (Tnfaip6) genes, genes associated with 
normal cumulus expansion.  Additionally, EVs from small follicles induced granulosa 
cell proliferation, and we determined that the Src and JNK pathways were involved in the 
cell proliferation induced by EVs.  Moreover, we determined that the differential ability 
of EVs to affect granulosa cell proliferation was primarily a result of preferential uptake 
by EVs from small follicles versus those of medium and large follicles.  In summary, 
these studies provide insight into the unique characteristics of EVs isolated from three 
different stages of antral follicles.  This work also provides the first functional evidence 
that EVs from ovarian follicular fluid are able to elicit functional physiologic changes in 
both cumulus and granulosa cells and provides clues to the cell signaling pathways that 
are modulated in cells following exposure to these small lipid enclosed vesicles.  Lastly, 
this study provides an approach to further purify EVs, and indicates the ovarian follicle as 
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VII. Chapter I: Introduction  
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Eukaryotic cells are highly specialized cells with different organelles including 
endoplasmic reticulum, trans-Golgi network, mitochondria, carrying out distinct 
functions.  Within cells the crosstalk between organelles through exchange of bio-
informative materials, such as nucleic acid and proteins, is critical for maintaining a 
healthy cellular function.  One mechanism used by these organelles to communicate is 
via membrane derived bi-layer vesicles.  These vesicles are known to be capable of 
transferring molecules from one organelle to the other in a well-controlled manner of 
secretion and uptake (Vassilieva and Nusrat 2008).   
Vesicles outside the cells were first observed by Dr. H. Clark Anderson, a University 
of Kansas Medical Center faculty soon after the invention of electron microscopy in 1967 
(Anderson 1967).  In 1971, Dr. N. Crawford reported the observation of proteins on/in 
the vesicles and studies have been focused on the vesicle-associated proteins in different 
systems (Crawford 1971).  Dendritic cells and B lymphocytes secreted vesicles, which 
contained the major histocompatibility complex (MHC) class II antigen, were able to 
induce antigen-specific MHC class II-restricted T cell responses (Raposo, Nijman et al. 
1996, Thery, Duban et al. 2002).  Oligodendrocytes, which are responsible for 
myelinating axons in the brain, released vesicles containing proteolipid protein (PLP), 
myelin proteins and proteins associated with protection against oxidative stress (Kramer-
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Albers, Bretz et al. 2007, Fruhbeis, Frohlich et al. 2013, Frohlich, Kuo et al. 2014, 
Budnik, Ruiz-Canada et al. 2016).  Sphingomyelin present on tumor secreted vesicles 
was capable of stimulating endothelial cell migration and angiogenesis (Kim, Lee et al. 
2002).  In 2007, RNA transcripts were shown to be present in extracellular vesicles and 
this single manuscript, which has now been cited over >2500 times, signaled the start of a 
major effort in understanding of the potential biological roles these extracellular vesicles 
might have on cell, tissue and organ systems (Valadi, Ekstrom et al. 2007).  
Additionally, it was discovered that cancer cells excrete large numbers of vesicles and 
this lead to the hypothesis that these vesicles might be important in mediating changes in 
those cells immediately adjacent to the tumor cells to provide a niche for tumor growth.  
This also led to a large number of studies looking at vesicles in bodily fluids as 
biomarkers for cancers, and a significant portion of these papers focus on the composition 
of microRNA (miRNA) present in the vesicles (Ciardiello, Cavallini et al. 2016).  What 
has lagged behind is the potential of these vesicles to elicit important functions in normal 
physiology.  I believe that the antral ovarian follicle, due to its unique structure and 
well-established cross talk across this fluid filled space provides an excellent opportunity 
to study extracellular vesicles in a normal physiologic environment.   
 Vesicles can be released into extracellular space by different cellular mechanisms 
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and are categorized by the type of biogenesis and secretory method.  Two major 
mechanisms are thought to predominate during the formation and secretion of vesicles.   
These include the direct budding of the plasma membrane into the extracellular space 
(microvesicles) and the fusion of multivesicular bodies (MVB), which contain small 
intraluminal vesicles (commonly referred to as exosomes).  In addition, the process of 
apoptosis can also contribute a population of vesicles into the extracellular space.  Since 
there is a lack of knowledge/methodologies to distinguish the vesicles once released by 
the cells, they are more appropriately called extracellular vesicles (EVs), to indicate the 
unknown source of these biofluid vesicles.  The two most recognized populations of 
EVs (i.e. exosomes and microvesicles) will be discussed below with regard to their 
biogenesis.  
 
1. Extracellular vesicle biogenesis 
Exosome biogenesis 
Exosomes are a product of the endocytic pathway.  In endocytosis, the late 
endosome, also called MVB, contains intraluminal vesicles (ILV), produced by inward 
budding of the MVB membrane (Kowal, Tkach et al. 2014).  The well-established 
downstream pathway for MVB is to fuse with the lysosome to degrade the cellular 
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products contained within.  Alternatively, the MVB can fuse with the plasma membrane 
and the contents including the ILVs are then released into the extracellular space.  This 
was first described by two groups studying reticulocyte maturation and these endocytic 
small vesicles (ILV) were named exosomes for the first time by Johnstone et al. in 1987 
(Johnstone, Adam et al. 1987). 
Since exosomes originate from ILV the regulation of the biogenesis of ILV affects 
exosome production.  As a structure with a lipid bi-layer shell, production of ILV 
requires lipids these are mostly provided by recycling of the plasma membrane.  
Endosomal Sorting Complex Required for Transport (ESCRT) machinery is known to 
regulate membrane remodeling and then affect ILV formation in MVB (Hurley 2015).  
There are four complexes of ESCRT (ESCRT-0, ESCRT-I, ESCRT-II, ESCRT-III) and 
accessory proteins, which are also necessary for remodeling of plasma membrane.  The 
components of ESCRT are well described by Williams et al. (Figure 1) (Williams and 
Urbe 2007).  
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Figure 1 The ESCRTs  
The four ESCRTs are recruited to endosomes by their interactions with membranes, 
clathrin, ubiquitin (Ub) and with each other. Features common to both yeast and 
mammalian pathways are included.  Lipid recognition of either phosphatidylinositol-3-
phosphate (PtdIns3P) by the FYVE domain of Vps27 (ESCRT-0) or the GLUE domain of 
Vps36 (ESCRT-II), or PtdIns(3,5)P2 by Vps24 (ESCRT-III) might contribute to the early 
or late endosomal localization of the components.  All of the ESCRTs except ESCRT-III 
recognize and bind the ubiquitylated cargo, either through an ubiquitin-interacting motif 
(UIM) (ESCRT-0), an ubiquitin E2 variant (UEV) domain (ESCRT-I) or the GLUE 
domain of Vps36 (ESCRT-II).  ESCRT-III orchestrates the last steps in the pathway in 
which ubiquitin is removed by a de-ubiquitinase (degradation of alpha-4 (Doa4)), and the 
complexes are disassembled by the AAA+ ATPase Vps4.  Budding away from the 
cytosol is depicted as being facilitated by a curvature-inducing factor that could flex the 
membrane by being localized to the neck of the budding vesicle.  The ESCRT 
components might facilitate the recruitment of such curvature-inducing factors or the 
concentration of inverted cone-shaped components in the endosomal membrane, such as 
lysobisphosphatidic acid (LBPA), and non-cargo transmembrane proteins that have bulky 
glycosylations on the luminal side of the membrane, such as tetraspannins.  Did2, Vps2 
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and Vps60 are shown interacting with the Vps4–Vta1 complex.  The bottom panels list 
ESCRT subunits and accessory proteins from Saccharomyces cerevisiae and their 
mammalian homologues.  AMSH, associated molecule with the SH3 domain of STAM; 
CHMP, charged MVB proteins; SH3, Src-homology-3; STAM, signal transducing 





Permission to use this figure was kindly provided by the author, Dr. Roger Williams.  
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ESCRT-0 is responsible for cargo loading in an ubiquitin-dependent manner.  Two 
key components of ESCRT-0 have been reported to affect the production of exosomes, 
HGF-regulated tyrosine kinase substrate (HRS) and signal transducing adaptor molecule 
(STAM1), in which depletion of these two factors decreases the number of exosomes 
released (Colombo, Moita et al. 2013).  ESCRT-I is also involved in exosome secretion 
since depletion of Tumor Susceptibility 101 (TSG101) caused a decrease in exosome 
production (Colombo, Moita et al. 2013).  Within components of ESCRT-II and ESCRT-
III, the effect of single protein depletion is divergent except for CHMP4C (Baietti, Zhang 
et al. 2012, Colombo, Moita et al. 2013).  Knocking down the expression of CHMP4C 
decreased secretion of exosomes.  Alix is an ESCRT accessory protein that has been 
widely used as an exosome marker because of its consistent presence in different 
exosome preparations (Mathivanan, Ji et al. 2010).  Studies have tried to identify the 
influence of alix depletion on exosome secretion because of its ability to induce ILV 
budding (Baietti, Zhang et al. 2012).  While there is evidence showing that alix can 
affect specific populations of exosomes including CD81, CD63, MHC class II positive 
exosomes, the effect is not clear for the total number of exosomes produced by cells 
(Colombo, Moita et al. 2013, Romancino, Paterniti et al. 2013, Kowal, Tkach et al. 
2014).  Another critical protein in the ESCRT pathway is VPS4, an ATPase involved in 
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membrane scission (Hanson and Cashikar 2012).  The role of VPS4 in exosome 
biogenesis is not clear, as its effects on exosome secretion are dependent upon the cell 
line being studied (Baietti, Zhang et al. 2012, Abrami, Brandi et al. 2013, Colombo, 
Moita et al. 2013). 
In addition to the ESCRT pathway, there are also ESCRT-independent mechanisms 
capable of producing exosomes.  Ceramide, a major component of the lipid bi-layer, is 
able to induce inward budding and increase the production of exosomes by inducing the 
inward curvature of MVB membranes (Trajkovic, Hsu et al. 2008).  Accumulation of 
cholesterol, another major component of the plasma membrane, can also increase the 
number of exosomes (Strauss, Goebel et al. 2010).  Phospholipase D2 (PLD2) is also 
reported to have similar actions as ceramide, since the increase of PLD2 results in ILV 
inward budding and therefore increased exosome production (Laulagnier, Grand et al. 
2004, Ghossoub, Lembo et al. 2014). 
Other than vesicle formation, regulation of MVB trafficking and fusion with plasma 
membrane is another factor critical to exosome secretion.  RABs, which are small 
GTPase proteins, play important roles in several steps of vesicle trafficking and are 
essential for membrane budding, vesicle movement, and membrane docking and fusion 
(Stenmark 2009).  Within the RAB family, individual RABs including RAB2B, 
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RAB5A, RAB7, RAB9A, RAB11A, RAB27A, RAB27B, and RAB35 have been shown 
to be involved in various steps of vesicle trafficking and having different roles based on 
the cell type (Savina, Fader et al. 2005, Hsu, Morohashi et al. 2010, Ostrowski, Carmo et 
al. 2010, Baietti, Zhang et al. 2012, Bobrie, Krumeich et al. 2012, Peinado, Aleckovic et 
al. 2012, Abrami, Brandi et al. 2013, Fruhbeis, Frohlich et al. 2013). 
 
Microvesicle biogenesis 
In 1991, Stein and Luzio first defined microvesicles as vesicles shedding from 
plasma membrane (Stein and Luzio 1991).  Since both exosomes and microvesicles 
originate from lipid bi-layer membranes, they share some of the biogenesis machinery. 
ESCRT complexes, which I described above as important for exosome biogenesis, were 
originally shown to be important in membrane budding, docking, and scission reactions 
involved in microvesicle formation.  TSG101, an ESCRT-I subunit, interacts with alix 
and another accessory protein, arrestin-domain containing-1 (ARRDC1) in microvesicles 
(Nabhan, Hu et al. 2012).  Another similarity of exosome and microvesicle production 
can be observed by the enrichment of cholesterol, sphingomyelin, and ceramide implying 
that they are both related to lipid raft formation which is a microdomain of the plasma 
membrane with the enrichment of glycosphingolipids and membrane receptors (Bianco, 
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Perrotta et al. 2009).  A special mechanism to generate microvesicles is dependent on a 
membrane-binding motor, myosin-1a (Myo1a).  The activity of this motor results in the 
accumulation of membrane at microvillar tips, which then leads to the formation of 
microvesicles (McConnell and Tyska 2007, McConnell, Higginbotham et al. 2009).  
The regulation of exosomes and microvesicles production has been pursued in 
various cell types and focused on different cellular pathways.  Since they are both 
membrane-enclosed vesicles and require sources of membrane for biogenesis, some 
fundamental genes of membrane remodeling contribute to both exosomes and 
microvesicles.  Moreover, after being released into the extracellular space, it is difficult 
to distinguish and separate them from one to the other.  Therefore, the field has started 
to use the term “extracellular vesicle, EV” to refer to the vesicles isolated from biofluids 
(Cocucci and Meldolesi 2015).  I will use the inclusive EV term in my dissertation.  
 
2. Extracellular vesicles uptake  
In order for cells to use EV and the molecules (ie., nucleic acids, proteins, and lipids) 
contained within the recipient cells must have mechanisms to internalize or fuse with the 
EVs.  The ability of the cells to take up EVs has been proven by different methods, 
indirect and direct.  The transfer of mRNA, miRNA, or protein between cells from 
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different species by EVs has been shown by use of species specific primers or antibodies 
(Valadi, Ekstrom et al. 2007, Alvarez-Erviti, Seow et al. 2011).  Another mechanism is 
through use of reporter-based experiments where EVs were loaded with substrate that 
upon deliver/fusion to recipient cells can activate expression of a reporter construct in the 
recipient cells (Montecalvo, Larregina et al. 2012).  Other than the observation of cargo 
delivery, the uptake of EVs can also be visualized directly by labeling EVs with 
fluorescence markers (Montecalvo, Larregina et al. 2012).  Lipophilic dyes are the most 
common methodology to label the lipid bi-layers of EVs, these include PKH26, PKH67, 
rhodamine B (R18), DiI, and DiD.  Permeable dyes are the other alternative way to stain 
EVs, such as carboxyfluorescein succinimidyl ester (CFSE) and 5(6)-carboxyfluorescein 
diacetate (CFDA) (Mulcahy, Pink et al. 2014).  These compounds become confined to 
the cytosolic lumen and fluoresce as a consequence of esterification (Mulcahy, Pink et al. 
2014).  To determine the uptake of EVs in recipient cells, flow cytometry and confocal 
microscopy are two general approaches used.  Confocal microscopy can only show 
uptake of the EVs and the localization of EVs in the cells after internalization.  Flow 
cytometry can quantify the relative level of uptake and is capable of making comparison 
across experimental subjects.  When observing labeled EVs under confocal microscopy, 
it is also worthwhile noticing that it is not a single EV but a group of EVs that are 
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typically being detected due to the limited resolution of light based microscopes.  There 
are several ways that recipient cells can take up EVs in the extracellular space including 
various types of endocytosis, membrane fusion, and specific protein-dependent 
internalization, which will be discussed below. 
 
Clathrin-dependent endocytosis 
This type of endocytosis requires clathrin for the formation of clathrin coated 
vesicles to internalize extracellular materials (Kirchhausen 2000).  Since this pathway 
has been well studied, there are numerous approaches to manipulate the process and to 
test the role of clathrin-dependent endocytosis on EV uptake.  Chlorpromazine prevents 
formation of clathrin-coated pits at the plasma membrane and treatment with 
chlorpromazine decreased the uptake of EVs in ovarian cancer cells (Wang, Rothberg et 
al. 1993, Feng, Zhao et al. 2010, Escrevente, Keller et al. 2011).  Two proteins, 
dynamin2 and epidermal growth factor receptor pathway substrate clone 15 (EPS15) are 
essential components in clathrin-dependent endocytosis.  Regulating these proteins 
negatively in the cells decreased EV uptake (Barres, Blanc et al. 2010, Feng, Zhao et al. 





Caveolin-dependent endocytosis shares some similarities with clathrin-dependent 
endocytosis but requires the formation of caveolae, a type of lipid raft present on the 
plasma membrane.  Dynamin2 is also a component in this process, therefore the 
decrease of EV uptake by blocking dynamin2 illustrates that EVs are taken up at least 
partially through this pathway (Barres, Blanc et al. 2010, Menck, Klemm et al. 2013, 
Nanbo, Kawanishi et al. 2013).  In order to look into the role of caveolin-dependent 
endocytosis on EV uptake more specifically, knock-down of caveolin-1 (CAV1), which 
is required and sufficient for the formation of caveolae, was performed, and impaired EV 
uptake was observed (Nanbo, Kawanishi et al. 2013).  However, knock-down of CAV1 
resulted in increased EV uptake in another study using a different cell type (Svensson, 
Christianson et al. 2013).  
 
Macropinocytosis 
Macropinocytosis is a type of endocytosis, which involves the formation of 
invaginated membrane ruffles and inward membrane budding at these sites.  This 
mechanism is rac1-, actin- and cholesterol-dependent and requires Na+/H+ exchanger 
activity (Kerr and Teasdale 2009).  Inhibition of Na+/H+ exchanger with amiloride was 
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able to decrease uptake of EVs by microglia cells (Fitzner, Schnaars et al. 2011).  
Treatment with a small molecule inhibitor of rac1, NSC23766, inhibited the uptake of 
EVs by microglia (Fitzner, Schnaars et al. 2011).  However, studies with other cell types 
did not observe inhibition of EV uptake following blockade of macropinocytosis (Feng, 
Zhao et al. 2010, Christianson, Svensson et al. 2013, Nanbo, Kawanishi et al. 2013).  
Therefore, the role of macropinocytosis on EV uptake appears to be cell type dependent. 
  
Phagocytosis 
Phagocytosis is yet another type of endocytosis.  Phagocytosis usually happens in a 
receptor mediated manner and is known to internalize larger extracellular materials.  
Phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) is critical in phagocytic processes, 
particularly in enabling membrane insertion into the forming phagosomes (Stephens, 
Ellson et al. 2002, Mulcahy, Pink et al. 2014).  Inhibition of PI3K activity using small 
molecule inhibitors, such as LY294002 and wortmannin, can abolish EV uptake in a 
dose-dependent manner (Feng, Zhao et al. 2010).  Phosphatidylserine (PS), a 
phospholipid of the membrane, is another molecule that has been shown to play a role in 
phagocytosis-mediated EV uptake.  Macrophages cultured in presence of an antibody 
against T-cell immunoglobulin mucin protein 4 (TIM4), which is a critical receptor 
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involved in PS-dependent phagocytosis, reduced the uptake of EVs (Miyanishi, Tada et 
al. 2007, Feng, Zhao et al. 2010).  Additionally, treatment with a PS analogue reduced 
uptake of EVs by dendritic cells as did incubation of macrophages and natural killer cells 
with a PS-binding protein, annexin-V (Nolte-'t Hoen, Buschow et al. 2009, Yuyama, Sun 
et al. 2012).  
  
Lipid rafts 
Lipid rafts are specialized regions on the plasma membrane, which are rich in protein 
receptors, sphingolipids, and cholesterol (Nabi and Le 2003).  Endocytosis depending 
on cholesterol are highly associated with lipid rafts, such as clathrin- and caveolin-
dependent endocytosis.  Flotillins represent another type of protein in the lipid rafts, 
which are also involved in endocytosis (Palecek, Schmidt et al. 1996).  The endocytosis 
mediated by flotillins are independent from clathrin and caveolin and likely work through 
binding to GPI-anchored proteins (Glebov, Bright et al. 2006, Frick, Bright et al. 2007, 
Otto and Nichols 2011).  Disruption of lipid rafts composition using drugs, such as 
fumonisin B1, N-butyldeoxynojirimycin hydrochloride, MβCD, filipin and simvastatin 
were all shown to influenced EV uptake, indicating the critical role of lipid rafts in EV 
uptake (Parolini, Federici et al. 2009, Feng, Zhao et al. 2010, Escrevente, Keller et al. 
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2011, Koumangoye, Sakwe et al. 2011, Montecalvo, Larregina et al. 2012, Svensson, 
Christianson et al. 2013). 
 
Membrane fusion 
The other way to deliver signaling molecule by EVs is through membrane fusion 
which is dependent on Soluble NSF Attachment Protein Receptors (SNAREs), Rab 
proteins, and Sec1/Munc-18 related proteins (SM-proteins) (Jahn and Sudhof 1999).  
Fusion of EVs to recipient cells can be observed by using fluorescence lipid dequenching, 
followed by detection of delivered materials using specific primers or antibodies 
(Parolini, Federici et al. 2009).  While the tools for measuring membrane fusion are 
available, currently very little is known/published regarding whether this is a mechanism 
that is used by EVs to deliver material from one cell to another cell.   
 
Specific protein interaction 
Other than known cellular mechanisms, EV uptake through interaction with 
individual membrane surface proteins has been explored as well.  Tetraspanins are a 
family of proteins with four transmembrane domains that are rich in EV preparations 
(Escola, Kleijmeer et al. 1998, Zoller 2009).  CD9, CD63, and CD81 from this family 
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are broadly used as markers for EVs (Escola, Kleijmeer et al. 1998, Thery, Regnault et al. 
1999).  Treatment of cells with CD9 or CD81 antibodies decreased EV uptake, 
suggesting an active role of these two tetraspanins in EV uptake (Morelli, Larregina et al. 
2004).  Another tetraspanin, Tspan8, is known to form a complex with CD49d and then 
is able to be taken up by endothelial cells and pancreatic cells through interactions with 
its ligand, intercellular adhesion molecule 1 (ICAM1/CD54) (Nazarenko, Rana et al. 
2010). 
The importance of integrins and immunoglobulins on EV uptake has been studied 
mostly in immune cells.  Blocking CD11a, ICAM1, CD51, and CD61 resulted in 
reduced EV uptake (Morelli, Larregina et al. 2004, Nolte-'t Hoen, Buschow et al. 2009).  
Naïve T-cells have been shown to internalize EVs through T-cell receptor (TCR), CD28, 
and function-associated antigen (LFA1; (Hwang, Shen et al. 2003).  CD4+ cells also 
require TCR-major histocompatibility complex (MHC) and LFA1-ICAM1 interaction to 
take up EVs (Hao, Bai et al. 2007).  These results emphasize the role of protein-protein 
interaction on EV uptake.  
Proteoglycans are proteins with high levels of carbohydrate.  The heparin sulphate 
proteoglycans (HSPGs) are proteins with sulphated glycosaminoglycan polysaccharides 
that participate in viral entry (Shukla, Liu et al. 1999).  Cells that have lost the ability to 
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produce normal HSPGs also show impaired ability to uptake EVs (Christianson, 
Svensson et al. 2013).  Extracellular vesicles pre-treated with heparinase to remove 
proteoglycans have reduced uptake by recipient cells indicating the importance of cell 
surface proteoglycans (Christianson, Svensson et al. 2013). 
Lectins are another group of proteins, which have been shown to be critical for EV 
uptake.  Treatment with antibodies against DC-SIGN or DE-205, both C-type lectin 
receptors, abolished EV uptake by dendritic cells (Hao, Bai et al. 2007, Naslund, Paquin-
Proulx et al. 2014).  Another leptin, galectin-5, has been found to associate with EVs, 
and co-incubation of EVs and excess galectin-5 reduced EV uptake (Barres, Blanc et al. 
2010).  Addition of asialofetuin, which binds to galetin-5, also reduced EV uptake 
(Barres, Blanc et al. 2010).  
The evidence provided above has shown that EVs can be taken up by the cells 
through different mechanisms and that they rely on different cellular proteins in a cell 
type dependent manner.  The EV uptake mechanisms in individual cell types and organ 
systems require to be further determined, and modulation of the identified EV uptake 





3. Ovarian antral follicle 
Ovarian antral follicle 
The most critical functions of the ovary are generation of a fertilizable and healthy 
oocyte and its role as an endocrine organ.  Ovarian follicles are functional units within 
the ovary, they are composed of three major cell types: the endocrine granulosa and theca 
cells, and the germ line, oocytes.  Granulosa cells, located inside the basal lamina of the 
follicle, are a major cell population within the ovary, while the less predominant theca 
cells reside just outside the basal lamina.  Orchestrated cross talk between these distinct 
cell types in addition to crucial gonadotropins from the pituitary, follicle-stimulating 
hormone (FSH) and luteinizing hormone (LH), ensures healthy folliculogenesis in which 
follicles grow from tiny primodial follicle (<0.1 mm) into a large periovulatory follicles 
(>15 mm) in women (Baerwald, Adams et al. 2012).  The structure of a follicle changes 
with growing follicle size, and a significant difference is the presence and expansion of 
the fluid-filled space, the antrum, within the follicle.  This space effectively separates 
the oocyte from the highly metabolic mural granulosa cells.  This specific feature gives 
rise to the name antral follicle.  The size of antral follicles is dependent upon the 





The antral space within the growing follicle contains follicular fluid, this fluid like 
most bodily fluids is thought to originate from osmotic differences and movement of 
fluids out of the vascular system into the tissues (Rodgers and Irving-Rodgers 2010).  
Thecal layers outside the basal lamina contain a vast capillary network that serves the 
growing follicle’s need for nutrients and removal of metabolic waste.  However, 
providing a route and a force to make the fluid flow into the antrum is another issue.  
The basal lamina and granulosa cells that separate the vasculature in the theca cell layer, 
and the antrum are tightly connected with each other, therefore channels or pumps are 
likely to play roles in this fluid transportation.  It has been found that aquaporins are 
responsible for pulling water into the follicular antrum and the isoforms of aquaporins 
required for this process are species dependent (McConnell, Yunus et al. 2002, 
Skowronski, Kwon et al. 2009).  One of the forces directing fluid flow is osmolality.  It 
has been shown that the tight basal lamina and granulosa cells prevent large molecules 
from moving in and out of follicles.  Therefore, the concentration of molecules in the 
follicular fluid may be able to control the osmolality between capillaries and follicular 
fluid, and then further control the fluid flow into the follicular antrum.  The volume of 
follicular fluid progressively increases in the growing follicle reaching it maximal 
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volume in the periovulatory follicle, immediately before ovulation (Rodgers and Irving-
Rodgers 2010).  It has been reported that increased concentrations of hyaluronan and 
versican are able to create osmolality differences, and the expression of both are 
controlled by LH (Clarke, Hope et al. 2006).   
 Other than supporting the structure of the follicle, the follicular fluid also provides 
an environment for exchanging information between different ovarian cell types.  
Therefore, the components in the follicular fluid are dynamic and physiologically 
relevant.  Proteomic studies using mass spectrometry (MS) is a powerful tool to reveal 
the composition of follicular fluid (Angelucci, Ciavardelli et al. 2006, Schweigert, 
Gericke et al. 2006, Hanrieder, Nyakas et al. 2008).  One of the study using three 
protein fractionation methods to deplete abundant serum-like proteins, 480 proteins were 
identified by MS analysis in human follicular fluid (Ambekar, Nirujogi et al. 2013).  
These proteins involve in metabolism, extracellular matrix (ECM) remodeling, and 
immune responses (Ambekar, Nirujogi et al. 2013).  Studies focusing on individual 
proteins such as cytokines and growth factors in follicular fluid have also been described.  
Improved oocyte quality has been linked with increased levels of granulocyte-colony 
stimulating factor (Ledee, Munaut et al. 2010, Ledee, Petitbarat et al. 2011, Ledee, 
Gridelet et al. 2013); interleukin (IL)-12, IL-6, IL-8, and IL-18 (Bedaiwy, Shahin et al. 
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2007, Sarapik, Velthut et al. 2012); brain derived neurotropic factor (Wu, Hu et al. 2012); 
and bone morphogenic protein 2 (Sugiyama, Fuzitou et al. 2010), as well as decreased 
levels of IL-1 and IL-12 (Mendoza, Ruiz-Requena et al. 2002) and vascular endothelial 
growth factor isoform 165 (Savchev, Moragianni et al. 2010).  Other than proteins, the 
balance between reactive oxygen species (ROS) and antioxidants in follicular fluid is 
critical to the production of a competent oocyte (Hennet and Combelles 2012).  
Blocking or suppressing ROS with antioxidants reversibly inhibited the resumption of 
meiosis in rat oocytes in vitro (Takami, Preston et al. 1999).  Excessive levels of ROS 
have been shown to cause aberrations to the microtubule organization and chromosomal 
alignment of metaphase II meiotic spindles in mouse oocytes in vitro (Choi, Banerjee et 
al. 2007), and to inhibit oocyte maturation in the mouse (Tamura, Takasaki et al. 2008).  
There are also hormones found in follicular fluid include FSH, LH, growth hormone 
(GH), human chorionic gonadotropin (hCG), progesterone, and estradiol (Hennet and 
Combelles 2012).  High follicular fluid concentrations of FSH, hCG, and LH seem to 
promote oocyte maturation and are correlated with a high probability of fertilization 
(Hennet and Combelles 2012).  High estradiol levels, especially in relation to androgen 
levels are also associated with high-quality oocytes and healthy follicles (Revelli, Delle 
Piane et al. 2009).  Metabolites including amino acids, lipids, nucleotides, and other 
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small molecules also present in follicular fluid (Hennet and Combelles 2012).  Linoleic 
acid, oleic acid, stearic acid, and palmitic acid have been shown abundant in the bovine 
FF (Bender, Walsh et al. 2010).  Evidence suggests that competent human oocytes 
generally contain relatively low levels of saturated fatty acids such as palmitic acid and 
stearic acid (Haggarty, Wood et al. 2006).  Moreover, saturated fatty acid levels in the 
FF of a high-fertility bovine model (heifers) are lower than those of a low-fertility model 
(cows) (Bender, Walsh et al. 2010).  Experimental exposure of cumulus-oocyte-complex 
to linoleic acid inhibited cumulus cell expansion and decreased the number of oocytes 
reaching metaphase-II (Marei, Wathes et al. 2010).   
 
Granulosa cell proliferation  
One of the factors inducing the growth of antral follicle size is the increasing number 
of granulosa cells.  This process is the result of decreased apoptosis and increased cell 
proliferation which are regulated by various signaling molecules.  Small antral follicles 
undergo high levels of cell proliferation until they reach the ovulatory stage.  Due to the 
importance of granulosa cell proliferation, a lot of work has been dedicated to 
understanding the various factors that can impinge upon this cellular aspect.  Below I 
describe several of the major pathways and factors that are implicated in granulosa cell 
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growth and proliferation.  
 
Estradiol  
In addition to being involved in the feedback loop of the hypothalamo-pituitary -
ovarian axis, granulosa cell produced estradiol can serve as autocrine and paracrine 
factors within the ovary.  Their receptors, ERα and ERβ are also expressed in granulosa 
cells in a species dependent manner (Rosenfeld, Wagner et al. 2001, Berisha, Pfaffl et al. 
2002, LaVoie, DeSimone et al. 2002, Juengel, Heath et al. 2006).  Deletion of either 
receptor results in complete or partial loss of fertility (Dupont, Krust et al. 2000).  
Estradiol signaling has been reported to inhibit the expression of p53 and Bcl2 
homologous antagonist/killer (Bax) in granulosa cells, which are both proapoptotic genes 
(Britt, Drummond et al. 2000, Toda, Takeda et al. 2001). 
 
Insulin-like growth factor (IGF) 
IGF and its receptor, type-I IGF receptor (IGF-IR) are both expressed in granulosa 
cells (Zhou, Chin et al. 1991, Yuan, Lucy et al. 1996, Adashi, Resnick et al. 1997, 
Wandji, Wood et al. 1998, Armstrong, Gutierrez et al. 2000, Liu, Koenigsfeld et al. 2000, 
Hastie and Haresign 2006).  Mice of IGF-1 knockout are infertile, and no large antral 
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follicles are observed indicating the importance of IGF signaling to antral follicle growth 
(Baker, Hardy et al. 1996, Zhou, Kumar et al. 1997).  One of the explanations is that 
IGF regulates the expression of FSH and LH receptors and the secretion of estradiol by 
granulosa cells (Adashi, Resnick et al. 1985, Hsu and Hammond 1987, Maruo, Hayashi et 
al. 1988, Monniaux and Pisselet 1992, Zhou, Kumar et al. 1997, Khalid, Haresign et al. 
2000, Glister, Tannetta et al. 2001). 
 
Phosphophatidylinositol 3-kinase (PI3K)-AKT signaling 
PI3K-AKT signaling is at the center of the anti-apoptosis signaling in granulosa 
cells.  The activation of this pathway results in phosphorylation of the forkhead box O 
(FOXO) subfamily of forkhead transcription factors (Brunet, Bonni et al. 1999, Dijkers, 
Birkenkamp et al. 2002, Stahl, Dijkers et al. 2002, Accili and Arden 2004).  
Phosphorylation of FOXO then prevents its translocation into the nucleus, and therefore 
the failure of translocation in turn then prevents expression of the cell death related 
genes, Fas ligand (FASLG) and BCL211 (Matsuda, Inoue et al. 2011). 
 
Transforming growth factor β (TGFβ) superfamily  
This is a large protein family including inhibin, activin, follistatin, TGF, bone 
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morphogenetic protein (BMP), growth differentiation factor (GDF), and anti-mullerian 
hormone (AMH).  Activin has been shown to be expressed in the granulosa cells, and 
able to induce granulosa cell proliferation in the antral follicles of rat (Li, Phillips et al. 
1995, Miro and Hillier 1996).  Expression of AMH decreases with the increase of 
follicle size, and is also associated with the increase of aromatase expression indicating a 
role of AMH on follicle growth through the regulation of estradiol production (Andersen, 
Schmidt et al. 2010, Grondahl, Nielsen et al. 2011).  BMPs and GDFs are widely 
expressed in the ovary in a cell type specific manner (Knight and Glister 2006).  
Oocyte-derived GDF9, BMP6, and BMP15 have been shown to be able to induce 
granulosa cell proliferation as paracrine agents at the antral stage.  BMP2, BMP5, and 
BMP6 secreted from granulosa cells have described autocrine and paracrine roles of 
promoting granulosa cell proliferation in the antral follicle (Fatehi, van den Hurk et al. 
2005). 
Tumor necrosis factor alpha (TNFα) 
Tumor necrosis factor alpha also plays a critical role in the antral follicle.  Tumor 
necrosis factor alpha has been reported to be able to induce granulosa cell proliferation in 
the mouse through IGF signaling and the acute phase protein serum amyloid A3 (Son, 
Arai et al. 2004, Son, Roby et al. 2004).  Tumor necrosis factor alpha is also known to 
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be able to activate nitric oxide synthase 2 (NOS2), in which its downstream product, NO 
can promote granulosa cell proliferation (Hattori, Sakamoto et al. 1996).  Paradoxically, 
TNFα has also been linked to apoptosis while TNFα knockout mice showed increased 
granulosa cell proliferation (Cui, Yang et al. 2011).  Tumor necrosis factor alpha was 
also shown as downstream of nerve growth factor (NGF) and mediated apoptosis of 
granulosa cell in mice (Son, Roby et al. 2004).  The receptors for TNFα, TNF receptor 1 
and 2 (TNFR1 and TNFR2) may play a critical role on this dual function of TNFα 
signaling since TNFR1 has been linked to cytotoxicity and TNFR2 to proliferation 
(Tartaglia, Weber et al. 1991).  
 
4. Extracellular vesicles in ovarian antral follicles 
Since EVs appear to be produced by all normal cells, it is not surprising that the 
ovarian cells also secrete EVs.  These EVs would be predicted to be enriched in 
follicular fluid, particularly those from granulosa cells and cumulus cells due to 
immediate proximity to the fluid and the enclosed environment of ovarian follicle.  In 
2012, the first published observation of EVs in follicular fluid was made by da Silveira et 
al. (da Silveira, Veeramachaneni et al. 2012).  These authors collected EVs from equine 
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follicular fluid of follicles (>35 mm) 32 h after hCG injection from mares of two different 
ages, young (3-13 years) and old (>20 years).  EVs were collected by 
ultracentrifugation.  Two-dimensional mass spectrometry was applied to the EVs taken 
from young mares and revealed proteins that had not previously been identified in/on 
EVs of different cellular origin.  The EV-contained miRNA were compared between 
young and old mares using Human miRNome Profiler plates, and the differences were 
linked to WNT, MAPK, focal adhesion, and TGFβ pathways.  In vivo uptake of EVs 
was also observed following injection of fluorescence labeled EVs back into antral 
follicles.  
This study was followed by several other studies by other laboratories, which 
focused on the cargos of follicular EVs, particular miRNA.  Sohel et al. collected 
bovine follicular fluid and classified them by the representative oocyte, as either mature 
or growing oocyte, using Brilliant Cresyl Blue (BCB) staining (Sohel, Hoelker et al. 
2013).  In this study, EVs were isolated from follicular fluid using Exoquick, an 
exosome precipitation kit.  MicroRNA were profiled by ready-to-use PCR Human 
Panels (I+II), and the differential miRNA were linked to ubiquitin-mediated, neutrophin, 
MAPK, and insulin signaling. 
Sang et al. collected follicular fluid from women undergoing in vitro fertilization 
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(IVF) who had polycystic ovary syndrome (PCOS) and were undergoing 
intracytoplasmic sperm injection treatment (ICSI) (Sang, Yao et al. 2013).  Follicular 
fluid from follicles 18-20 mm in size were collected 34-36 h after hCG injection. In their 
study, it is worthwhile pointing out that microvesicles can be a significant part of their 
EV samples because of the ultracentrifugation protocol they used.  The differential 
presented miRNA in follicular EVs between control and PCOS patients were determined 
by TaqMan Array Human MicroRNA A and B Cards Set version 3.0, and the miRNA 
were predicted to affect genes which have been shown important generally in ovary or 
particularly in PCOS including estrogen receptor (ESR1), pTEN, ILs, TGFβ1, HMGA, 
and RAB5B.  MicroRNA-132 and -320 were present at a low level in the follicular fluid 
of PCOS patients, which might indicate a potential use as biomarkers clinically.  
Santonocito et al. used the same protocol as Sang et al. to isolate follicular fluid from 
healthy women who were undergoing ISCI due to male factors, and their plasma samples 
were used as the control (Santonocito, Vento et al. 2014).  EVs were isolated by 
ultracentrifugation, and the profile of miRNA was completed on TaqMan Human 
MicroRNA Array A cards.  MicroRNA which were detected differentially between 
plasma and EVs linked to TGFβ, MAPK, ErbB, and WNT signaling.   
Diez-Fraile et al. conducted a similar study comparing follicular EV-associated 
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microRNA between young (<31 years) and old (>38 years) women (Diez-Fraile, 
Lammens et al. 2014).  The authors found four microRNA, which were specific to only 
one of the two groups including miR-21-5p in young women and miR-99b-3p, miR-134, 
miR-190b in old women.  Targets of these microRNA were predicted to relate to 
heparan-sulfate biosynthesis, extracellular matrix–receptor interaction, carbohydrate 
digestion and absorption, p53 signaling, and cytokine–cytokine-receptor interaction.   
The studies described above show that EVs are highly abundant in follicular fluid of 
different species (mare, cow, and women), and that the EVs contain microRNA that are 
physiological relevant.  However, none of these studies demonstrated a functional effect 
of EVs within the ovary, the first study to do so was carried out by da Silveira et al. (da 
Silveira, Carnevale et al. 2014).  In their study, they detected genes in the TGFβ/BMP 
pathway expressed in the mare granulosa cells of mid-estrus and pre-ovulatory follicles.  
They also found that the follicular EVs from the same staged follicles contained miRNAs 
(i.e., miR-27b, miR-372, and miR-382) that can target these TGFβ/ BMP pathway related 
genes.  To demonstrate activity of follicular EVs, mare granulosa cells were treated with 
follicular EVs.  They found that the EVs from both mid-estrus and pre-ovulatory 
follicles could decrease granulosa cell expression of inhibitor of DNA 
binding/differentiation 2 (ID2), which is a target of miR-27b, miR-372, and miR-382.  
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This result indicated for the first time that follicular EVs could elicit functional effect.  
But since the follicular EVs from both mid-estrus and pre-ovulatory follicles suppressed 
the expression of ID2 similarly, the physiological roles of follicular EVs are still not clear 
and needed to be further explored.  
 
5. Significance  
The increasing role of EVs as a cell-cell communication mediator has been proven in 
multiple organs and different types of cells.  In cancer cells, EVs have been known to 
promote cancer cells metastasis (Tkach and Thery 2016).  Tumor cells secreted EVs 
have the ability to facilitate remodeling of the extracellular matrix (ECM) (Clancy, 
Sedgwick et al. 2015, Hoshino, Costa-Silva et al. 2015, Sung, Ketova et al. 2015, Yue, 
Mu et al. 2015).  Moreover, tumor cell secreted EVs can travel to pre-metastatic sites 
and set up the microenvironment favorable for tumor cells before metastasis (Peinado, 
Aleckovic et al. 2012, Zhou, Fong et al. 2014, Costa-Silva, Aiello et al. 2015, Hoshino, 
Costa-Silva et al. 2015).  EVs also have been reported as critical players in the 
neurogenic niche (Batiz, Castro et al. 2015).  In Drosophila, exosomes have been 
described as cell-cell communication mediators between pre- and post-synaptic cells 
(Korkut, Li et al. 2013).  Cross-talk between different neuronal cell types by EVs also 
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has been shown (Fitzner, Schnaars et al. 2011, Fruhbeis, Frohlich et al. 2013, Fruhbeis, 
Frohlich et al. 2013, Bahrini, Song et al. 2015), and the function of EVs is specific to 
cellular environment such as nutrition deprivation (Fruhbeis, Frohlich et al. 2013).  The 
existence of EVs in the ovarian follicles has been reported by several groups as discussed 
above, and the potential functions of these EVs have been predicted based on the EV-
contained miRNA.  However, demonstration of a physiological function for the 
follicular EVs has not been well explored.  In this dissertation, follicular EVs from 
different sized follicles were first characterized, and their effects on ovarian granulosa 
cells and cumulus-enclosed oocytes were tested.  These studies provide another layer of 
information on the cellular mechanisms responsible for appropriate follicle growth, and 
demonstrate for the first time specific functions of these membrane-enclosed vesicles, 











VIII. Chapter II: Characterization and Small RNA Content of 
Extracellular Vesicles in Follicular Fluid of Developing Bovine 




 Cell-to-cell communication between somatic cells (theca, granulosa, and cumulus) 
and germ cells (oocytes) are critical for the process of folliculogenesis (Eppig 2001, 
Matzuk, Burns et al. 2002).  During folliculogenesis, the coordinated communication 
and signaling between the different follicular cell types is crucial for growth, maturation, 
and release of an oocyte that can be fertilized and undergo embryonic development.  
The endocrine hormones, follicle stimulating hormone (FSH) and luteinizing hormone 
(LH), play key regulatory roles in all aspects of this developmental progression from a 
preantral to a periovulatory follicle.  Additionally, growth factors within the 
periovulatory follicle are essential for transmission of these endocrine signals to the 
deeper residing cumulus cells and oocyte within the follicle (Espey and Richards 2002, 
Park, Su et al. 2004, Conti, Hsieh et al. 2006, Carletti, Fiedler et al. 2010).  Likewise the 
oocyte secretes factors (i.e., GDF-9, BMP15) that are able to influence the nearby mural 
granulosa cells (Galloway, Gregan et al. 2002, Mazerbourg and Hsueh 2003).  The 
antrum that separates these distinct cells is filled with a complex fluid derived from both 
blood plasma that arises from increased permeability of the thecal capillaries and release 
of secretory factors from both types of granulosa cells and oocytes (Espey 1980, 
Cavender and Murdoch 1988).  Hormones (e.g., FSH, LH, GH, inhibin, activin, 
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estrogens, and androgens), growth factors, proteins, lipoproteins, peptides, amino acids, 
and nucleotides have been found to be enriched in follicular fluid and provide an 
important microenvironment for follicle growth and oocyte maturation (Fortune 1994, 
Revelli, Delle Piane et al. 2009).  However, with the exception of several growth factors 
and steroids, much of the material observed in follicular fluid has not been well 
characterized and very little is known about the functional role of these molecules.   
 Recent studies have demonstrated that membrane-enclosed vesicles called 
microvesicles which are heterogeneous in size (100–1000 nm) contain bioactive 
molecules such as proteins, messenger RNA (mRNA) and microRNA (miRNA) 
(Camussi, Deregibus et al. 2010, Muralidharan-Chari, Clancy et al. 2010) which are 
released from cells by outward budding and fission of the plasma membrane (Cocucci, 
Racchetti et al. 2009).  Similar to microvesicles, exosomes also have a lipid bilayer but 
are more homogeneous and smaller in size (30–100 nm).  Exosomes are derived from 
intraluminal invagination of the multivesicular bodies (MVBs), followed by fusion of the 
MVB with the plasma membrane and release of its exosomal cargo into the extracellular 
space (Valadi, Ekstrom et al. 2007, Lakkaraju and Rodriguez-Boulan 2008, Simpson, Lim 
et al. 2009, Vlassov, Magdaleno et al. 2012).  It should be noted that following cellular 
release the distinction of exosomes from microvesicles cannot be determined; they will 
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be referred to extracellular vesicles (EVs) from here on.  Recent evidence suggests that 
EVs can play important roles in cell-to-cell communication by transferring proteins, 
RNA, and miRNA molecules to target cells (Valadi, Ekstrom et al. 2007, Muralidharan-
Chari, Clancy et al. 2010).  Several studies have now confirmed the existence of EVs in 
follicular fluid of mares and women at different ages (da Silveira, Veeramachaneni et al. 
2012, da Silveira, Carnevale et al. 2014, Diez-Fraile, Lammens et al. 2014, Santonocito, 
Vento et al. 2014), in women with polycystic ovarian syndrome (Sang, Yao et al. 2013, 
Roth, McCallie et al. 2014), and in cow follicles at a single stage of development (Sohel, 
Hoelker et al. 2013).  Our recent work has documented that EVs from small and large 
cow follicles can differentially support cumulus expansion and changes in cumulus-
oocyte-complex (COC) gene expression (Hung, Christenson et al. 2015).  However, to 
date no studies have evaluated whether the numbers of vesicles and contents of these 
vesicles change during ovarian follicular development.  The cow was chosen for these 
studies for several reasons: the cow is a monoovulatory species with a similar temporal 
follicular growth and regression dynamics to that of the human (endocrine profiles do 
however differ between these species), the cow follicle provides sufficient levels of 
readily available fluid from early (small, 3-5 mm) antral follicles, samples that cannot be 
feasibly collected in humans or rodents for comparison to later-staged (medium, 6-9 mm 
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and large >9mm) antral follicles and understanding ovarian physiology in the cow has 
intrinsic value to the livestock industry.  
Materials and methods 
Follicular fluid collection 
Bovine ovaries were from a local abattoir: because the animals were not used specifically 
for research purposes our Institutional Animal Care and Use Committee ruled that the 
collection of ovaries from the abattoir does not constitute animal research and is exempt 
from further review.  Ovaries (~150 ovaries / collection) were placed immediately into 
PBS and then transported 2.5 h to the University of Kansas Medical Center at 20-24 C 
temperature in preparation for ovarian follicular fluid aspiration.  Follicular diameters 
were determined by individually measuring follicle diameters; follicles were designated 
into three different groups based on diameter (3-5 mm - small, 6-9 mm – medium and > 9 
mm – large).  Follicular fluid was aspirated using a tuberculin syringe (28 gauge needle) 
for small follicles and a 5 ml syringe with a 20-gauge needle for medium and large 
follicles.  The volume aspirated was used to confirm classification status (small < 50 μl, 
medium ~100 μl to 350 μl and large > 400 μl).  Three independent collections of 
follicular fluid were conducted over a two-month period for the RNAseq analysis.  Each 
collection provided the approximate volumes of follicular fluid: 20 ml from small, 15 ml 
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from medium and 40 ml from large follicles.  To determine relative follicle quality 
within the small, medium and large pools, 18-20 single follicles at each size were 
dissected free from the ovaries of a fourth collection of ovaries.  The granulosa cells 
were then isolated by bisecting each follicle and scraping the cells into PBS.  Cells were 
then fixed in 4% PFA, and stained with the DNA dye, Hoechst 33342 (Life Technologies, 
NY).  The nuclei of a hundred granulosa cells from each follicle were then classified as 
healthy (i.e., intact nucleus) or as apoptotic/atretic (i.e., fragmentized nucleus).  
Additionally, RIA conducted at the University of Virginia Center for Research in 
Reproduction Ligand Assay and Analysis Core determined estradiol and progesterone 
levels for each of the pools.  Each follicular fluid sample was diluted 1:15 fold in PBS 
for estradiol and 1:20 for progesterone prior to RIA.  The sensitivity of estradiol assay is 
10pg/ml with intra-assay CV of 6.3% and inter-assay CV of 8.1%. The sensitivity of 
progesterone assay is 0.15ng/ml with intra-assay CV of 5.7% and inter-assay CV of 
7.1%. 
Isolation of extracellular vesicles 
Extracellular vesicles were isolated using a differential ultracentrifugation method 
developed for serum isolation of exosomes (Thery, Amigorena et al. 2006).  Follicular 
fluid (15 ml) was diluted 1:1 with PBS and then spun at 800g and 2000g for 10 and 20 
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min each in an OptimaTM L-100XP to pellet all granulosa cells and the oocytes (the cell 
pellets were snap frozen at -80C or placed in Trizol).  The follicular fluid was then 
centrifuged at 12000g for 45 min to remove cellular debris and other large particles (large 
microvesicles and apoptotic blebs).  Samples were then filtered through a 0.22 μm pore 
filter to further remove vesicles bigger than 220 nm.  Ultracentrifugation of the 1:1 mix 
follicular fluid:PBS was performed at 110000g for 3h in an OptimaTM L-100XP 
ultracentrifuge, using a swinging bucket SW32Ti rotor.  The resulting EV pellets were 
then resuspended in 4 ml PBS and spun again for 1 h at 110000 g in a TLA 100.4 fixed 
angle rotor.  A final wash with 1 ml of PBS was then performed and spun at 110000 g 
for 1 h using a TLA 55 fixed angle rotor.  All centrifugations were performed at 4°C.  
The obtained pellets were re-suspended in PBS for further analysis. 
Separation of extracellular vesicles on sucrose gradient 
Extracellular vesicles isolated from follicular fluid using differential centrifugation were 
re-suspended in 100 µl of PBS and overlaid on the top of a continuous sucrose gradient 
(0.2 to 2.5 M sucrose in 20 mM HEPES, pH 7.4) which was made using a Hoefer SG30 
gradient marker (GE Healthcare, Piscataway, NJ).  The gradient tubes were centrifuged 
at 210,000g for 16 h at 4 °C in an SW41Ti swinging bucket rotor with an Optima-Max 
ultracentrifuge (Beckman Coulter).  Eleven 1 ml fractions were collected from the top to 
42 
 
bottom of the gradient and the refractive index of each collected fraction was measured 
using a VEE GEE refractometer (VEE GEE Scientific, Washington, USA). The sucrose 
density was converted from refractive index to density (g/cm3).  Each fraction was 
washed in 3 ml of PBS by ultracentrifugation at 110,000g for 1.5 h at 4 C using a TLA-100 
rotor in an Optima-Max ultracentrifuge and the pellets were re-suspended in PBS and 
loaded onto 12% SDS-PAGE for Western blot analysis. 
Western blot Analysis 
EV samples (10 μg protein) were lysed in SDS sample buffer with 50 mM DTT, heated 
for 5 min at 95 °C and subjected to electrophoresis using 12% SDS-PAGE in running 
buffer at constant 120 V for 1.5 hrs. Proteins were then electrotransferred onto 
polyvinylidenedifluoride membranes, and the membranes were blocked with 5 % (w/v) 
skim milk powder in Tris-buffered saline with 0.05 % (v/v) Tween-20 (TTBS) for 1h at 
RT. Membranes were then probed with primary anti-CD81 (sc-166029), anti-Alix 
(sc49267), anti-GP96 (sc-11402) and anti-Actin (sc-1616) antibodies for 1 h in TTBS (50 
mM Tris, 150 mM NaCl, 0.05 % Tween20) followed by incubation with the secondary 
anti-mouse IgG or anti-sheep goat antibodies for 1 h. All primary antibodies were 
purchased from Santa Cruz Biotechnology Inc. Membranes were washed three times in 
TTBS for 10 min after each incubation step and detected by enhanced 
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chemiluminescence (ECL) (GE Healthcare Bio-science, PA) per manufacturer’s 
instructions. 
Nanoparticle tracking analysis 
To determine particle size and concentration, nanoparticle-tracking analysis (NTA) was 
performed with a Nanosight LM10 instrument (Nanosight, Salisbury, UK) outfitted with 
a LM14C laser. Each EV preparation was sampled three times to generate 3 independent 
dilutions.  These dilutions range from ~1:1000 to 1:10,000 for each sample (the dilution 
is determined empirically for each sample) and then each of the three dilutions is 
analyzed 5 times (5 – 60 video tracks/dilution).  The overall average of these three 
dilutions was used as the experimental result for each sample.  If large discrepancies in 
counts were observed for a set of dilutions or if the range of particle concentrations were 
outside the optimum range, another dilution was then created from the stock and 
analyzed.  From validation studies using dilution series, we determined that NTA is most 
accurate between particle concentrations in the range of 2 × 108 /ml to 2 × 109 /ml.  
Thus samples were diluted to this level and absolute concentrations were then back 
calculated according to the dilution factor. 
Transmission electron microscopy 
An aliquot of the EV sample was pelleted and the PBS was replaced with 2% 
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gluteraldehyde fixative in 0.1 M cacodylate buffer.  Following overnight fixation, the 
fixative was carefully removed and replaced with 0.1M sodium cacodylate buffer 2 times 
for 5 min each. The pellet was then post-fixed in a solution of 1% osmium tetroxide plus 
with 1% potassium ferric cyanide buffered in 0.1 M cacodylate buffer for 1 h.  
Osmicated pellets were dehydrated through a series of graded ethanols, rinsed in 
propylene oxide 2 times for 10 minutes each and then embedded in fresh EMbed 812 
resin and cured in a 60°C oven overnight. Sections were cut at 80 nm using a Leica UC-7 
ultramicrotome, mounted on copper thin bar 300 mesh grids, and contrasted with 4 % 
uranyl acetate and Sato’s lead stain. All samples are examined in a JEOL-JEM-1400 
transmission electron microscope at an 80 kV with 25,000x magnification.  
RNA preparation 
Total RNA was isolated from EVs (20 μl) with Trizol (Invitrogen) according to the 
manufacturer’s protocol. Briefly, EVs were disrupted and homogenized in 200 μl of 
Trizol reagent and incubated for 5 min at room temperature. Samples were then spun in a 
microcentrifuge at 12000 g for 15 min at 4 °C following addition of 40 μl of chloroform.  
Subsequently, the aqueous solution was mixed with 100 μl of isopropanol.  In order to 
extract small RNA, 1 μl glycogen (20 μg/μl) was added together with RNA-isopropanol 
mixture solution and incubated at -80 °C for 30 min and spun at 12000 g for 15 min at 4 
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°C. The pellet was washed with 100 μl of 70 % ethanol followed by centrifugation at 
7500 g for 5 min at 4 °C. The RNA pellet was dried at room temperature and dissolved in 
10 μl of RNase free water. The RNA solution was then stored at -80 °C.  RNA quality, 
yield, and sizes were assessed with the Agilent 2100 Bioanalyzer (Agilent Technologies, 
Foster City, CA) using the Agilent Small RNA chip.  To confirm the absence of 18S and 
28S ribosomal RNA we also ran the RNA of the Agilent RNA 6000 Nano chips.  
Briefly, 1 μl of RNA was analyzed on either the Agilent RNA 6000 Nano or Small RNA 
chips according to manufacturer’s protocol.  Electropherograms were analyzed using the 
Agilent 2100 Expert B.02.07 software that includes data collection, presentation and 
interpretation functions.  The EV RNA purity was also evaluated using Nanodrop 
spectrophotometer ND-1000 (Thermo Scientific, Wilmington, DE) at the absorbance 230, 
260 and 280 nm.  The average A260/230 and A260/280 ratios were used to assess the 
presence of peptides, phenols, aromatic compounds, or carbohydrates and proteins. 
Next generation sequencing 
Small RNA sequencing was performed using the Illumina HiSeq2500 Sequencing System 
at the University of Kansas Medical Center – Genomics Core (Kansas City, KS).  
Extracellular vesicle RNA (ranging from 1.8 ng – 100 ng) was used to initiate the TruSeq 
Small RNA library preparation protocol (Illumina #RS200-0012 kit A).  The EV RNA 
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was ligated with 3’ and 5’ RNA adapters followed by a modified reverse transcription 
reaction and modified PCR amplification.  Due to low starting RNA quantities, the 
reverse transcription of the RNA adapter ligated samples was modified by performing 
two duplicate reactions containing 6 μl of the 3’/5’ RNA ligated RNA. The 12.5 μl yield 
of each duplicate reverse transcription reaction was then pooled to obtain 25 μl of 
homogeneous cDNA.  The subsequent PCR amplification, with index adapter 
incorporation, was modified by replacing 8.5 μl of ultra-pure water in the PCR master 
mix with 8.5 μl of the reverse transcribed and pooled cDNA (21 μl cDNA total).  The 
modified PCR reaction was performed with 15 cycles of amplification.  Size selection 
and purification of the cDNA library construct was conducted using 3 % marker H gel 
cassettes on the Pippin Prep size fractionation system (Sage Science).  The Agilent 2100 
Bioanalyzer was used with the High Sensitivity DNA kit (Agilent #5067-4626) or the 
DNA1000 kit (Agilent #5067-1504) to validate the purified libraries.  Libraries were 
quantified on the Illumina ECO Real Time PCR System using KAPA SYBR Universal 
Library Quant kit – Illumina (KAPA Biosystems KK4824).  Following quantification, 
libraries were adjusted to a 2 nM concentration and pooled for multiplexed sequencing.  
Libraries are denatured and diluted to the appropriate pM concentration (based on qPCR 
results) followed by clonal clustering onto the sequencing flow cell using the TruSeq 
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Rapid Single Read (SR) Cluster Kit-HS (Illumina GD402-4001).  The clonal clustering 
procedure was performed using the automated Illumina cBOT Cluster Station.  The 
clustered flow cell was sequenced on the Illumina HiSeq 2500 Sequencing System in 
Rapid Read mode with a 1x50 cycle read and index read using the TruSeq Rapid SBS kit-
HS (Illumina FC402-4002).  Following collection, sequence data was converted 
from .bcl file format to FASTQ files and de-multiplexed into individual sequences for 
further downstream analysis. 
Bioinformatics 
The three groups of EVs (small, medium and large) were analyzed in biological 
triplicates giving nine samples in total.  After 3' adapter removal, the read sequences 
were mapped using the bwa software (v 0.7.5a, (Li and Durbin 2009)) to the bovine 
genome (assembly UMD3.1) and annotated for overlapped regions with the Ensemble 
gene annotation file for bovine (release 70) and miRBase (release 21).  
Mapped reads from all 9 samples were merged and loci with an average read count per 
base (sum of the number of reads mapped at each base of the locus divided by its length) 
less than 45 were filtered out. These loci were then scanned for high-density regions 
defined as a contiguous region whose read count at each base is not less than 20% of the 
highest base read count for the locus. These high-density regions formed the effective 
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region of the locus and its length defined as its effective length. The number of reads 
mapped to the effective region of each sample formed the effective read counts that were 
used for down-stream analysis.  To further limit the number of loci identified to a more 
conservative “biologically relevant” number; loci with an average read count (over the 
three replicate samples) of 100 or greater in at least one of the three conditions (small, 
medium or large) were included for further analysis.        
Known and novel miRNA’s were identified from these loci through a systematic filtering 
process beginning with a length filter that filtered loci to those with an effective length 
between 18 and 30 bases. Effective regions that mapped to mature miRNA were first 
identified, while the remaining effective regions were compared to known miRNA from 
both bovine and other species found in miRBase (release 21).  A region was labeled as a 
miRNA by homology if it passed the following criteria; a gapless alignment of the 
effective region to the mature reference miRNA with at most 2 mismatches in the core 
and at most 1 gap/mismatch at the 5 and 3 prime ends and less than 10% mismatches in 
the alignment of the reference hair-pin sequence to the locus.  Novel miRNAs were 
identified based on the criteria that the extended effective region should have a predicted 
pre-miRNA like hairpin structure (Jiang, Wu et al. 2007) with the effective region falling 
in the stem region with at least 80% pairing.  The hybridization free energy cutoff was 
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set at -15 kcal/mol.  The raw sequence data available as GEO (GSE74879) has been 
uploaded to miRBase for annonation, a sortable Excel file format depicting all of the 
identified loci is available upon request. 
Exact statistical methods developed for multi-group experiments available from the 
edgeR software package (Robinson and Smyth 2008) were used to determine 
significantly differently expressed miRNAs between the different conditions.  The 
edgeR package employs advance empirical Bayes methods to estimate miRNA-specific 
biological variation under minimal levels of biological replication.  The associated p-
values were corrected for multiple-hypothesis testing by the Benjamini and Hochberg 
method (Benjamini, Drai et al. 2001).   
MiRNA function prediction 
Differentially expressed miRNAs (p < 0.05 and false discovery rate, FDR < 0.1) between 
two different sizes of follicle groups (large versus small, medium versus small and large 
versus medium) were used. Selected miRNAs were used to predict potential function 
through the use of QIAGEN’s Ingenuity® Pathway Analysis (IPA®, QIAGEN Redwood 
City, www.qiagen.com/ingenuity).  
Statistical Analysis  
All of the quantitative experiments (concentration of particles, steroid hormones 
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concentrations, ratio of miRNA in total small RNA) were repeated with at least 
independent three biological replicates. These results were analyzed by one-way ANOVA 
and Newman-Kuels multiple comparison tests were performed to determine differences 
amongst the means.  The GraphPad Prism version 5.00 for Windows, GraphPad 
Software, San Diego California USA was used for these analyses.   A p<0.05 was 
considered statistically significant.  The Chi-square test of homogeneity was used to 
determine if differences in proportions of miRNA significantly up and down regulated 
differed across the three comparisons of follicular fluid pools. The statistical analysis 
details for the next generation sequencing results are explained in detail in that section.  
Results 
Quantitation and morphological characterization of follicular fluid EV from growing 
antral follicles.   
 Bovine follicles subdivided by size (small, 3-5 mm; medium, 6-9 mm; and large >9 
mm) representing early to late stages of antral follicle growth were pooled by size to 
ensure enough material for initial EV collection and evaluation.  To provide an 
indication of the relative numbers of healthy follicles versus atretic follicles in each of the 
9 pools (i.e., three independent pools at each size), granulosa cells were isolated from a 
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subset (n=18-20) of individual follicles from each follicle stage.  Individual follicles had 
between 28 and 100% normal intact nuclear staining with the majority (~70%) of the 
follicles in each group containing less than 25% fragmented nuclei.  Compared across 
the follicular sizes, each pool thus contains between 71% to 81% intact nuclei (Fig II-1).   
Analysis of estrogen and progesterone levels in the 9 independent follicular fluid pools 
indicated that progesterone levels did not vary across the follicle sizes whereas estradiol 
concentrations increased with size as expected (Fig II-2).  
Total EV concentrations (x 1012 particles/ml of follicular fluid) were highest in the 
smallest diameter (3-5 mm) follicles and the number decreased progressively as follicle 
diameter increased (Figure II-3A).  EV size distributions ranged from ~30 to 300 nm as 
determined by nanoparticle tracking analysis (NTA) and there was no change in size 
distribution from the three different sized follicles (Figure II-3B).  Additionally, the 
mode and mean size of EVs was not significantly different in the three different follicle 




Figure II- 1 Percentage of non-apoptotic (normal) and apoptotic (fragmented DNA) 
granulosa cells from different size follicles.  







Figure II- 2 Progesterone and estradiol concentrations in follicular fluid from different 
size follicles.   






Figure II- 3 Particle concentrations and size distributions in EV preparations (n = 3) from 
small, medium and large follicles.  
(A) Mean concentration of particles (x 1012 particles per ml of follicular fluid). 
a,b,cMeans ± SEM with different superscripts were statistically different (P < 0.0001). 
(B) Nanoparticle tracking analysis predicted concentration and size distribution of 
particles in three representative EV preparations from follicular fluid of small, medium 






Table II- 1The mode and mean size of EVs from different sized follicles were determined 
by NTA. 
  follicle size (mm) 
  3-5 6-9 >9 
Mode (nm) 109 113 106 
Mean (nm) 124 134 127 




Several established exosome markers, tetraspanin CD81 and Alix were used to confirm 
the presence and enrichment of exosomes in the EV preparations (Figure II-4A).  We 
found that the expression of CD81 was highly expressed in EVs as compared to 
granulosa cells that were isolated from the initial 800 g centrifugation run in the EV 
isolation protocol (FigureII-4A).  Interestingly, the highest expression of CD81 was 
found in EVs (10 μg total loaded protein) derived from small follicles and decreased 
progressively in the EVs as follicle size increased (Figure II-4A).  Alix another exosome 
marker was also abundant in the EV preparations compared to the cell lysates; however, 
it did not show the same decrease in levels as that detected for CD81 as follicle size 
increased.  This later antibody/marker gene exhibited greater variation across samples 
and was considered less reliable.  The endoplasmic reticulum marker GP96 was 
detected in cell lysates and was not detectable in the EV preparations indicating the 
absence of other cellular membrane contamination in the EV preparations.  Actin was 
found in both EVs and cells (Figure II-4A).  Western blot analysis of CD81 in sucrose 
gradient fractions of small, medium and large follicle EV preparations indicated that EVs 
were found in fractions 5-9 of small and medium follicles at densities (1.14 to 1.25 
g/cm3) that are consistent with extracellular vesicles (i.e, exosomes; Figure II-4B).  The 
tetraspanin CD81 was not readily detectable in the large follicle EV preparations 
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following sucrose gradient analysis; this is likely due the decreased level of CD81 in the 
starting EV ultracentrifuge pellet “input” which is shown for each preparation (Figure II-
4B).  Transmission electron microscopy (TEM) revealed that the EV pellets contained a 
homogeneous population of circular bilayer enclosed vesicles with minimal evidence of 
protein contamination (very dark staining material that is not enclosed within a lipid 
bilayer: Figure II-4C).  We observed no vesicles >130 nm in diameter by TEM; however 
because these are cross-sectional views exact sizes are not determinable using this 
approach.   
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Figure II- 4 Quantitative and qualitative analysis of the EVs from small, medium and 
large follicles.  
(A) Western blot analysis of extracellular vesicle (CD81 and Alix), endoplasmic 
reticulum (GP96) and cellular (actin) markers in EV and cellular lysates. Equal amounts 
of total protein (10μg) were loaded into each lane. (B) Representative CD81 protein in 
sucrose gradient fractions of small, medium and large follicles. Each fraction density was 
determined by refractometry and an equal volume of the resulting resuspended pellets 
was loaded for western blot analysis (n = 3). Input represents an aliquot of the EV sample 
that was applied to the sucrose gradient. (C) Representative transmission electron 
microscopy image of a thin section through an EV pellet isolated from a small follicle–







Small RNAs within follicular fluid EVs 
A representative electropherogram for small, medium and large follicles shows the size 
distribution of small RNAs derived from the EV RNA isolation in the interval of 6-150 
nucleotides (Fig II-5A).  Note that the majority of the small RNA ranged in size between 
20 and 40 nucleotides in length consistent with microRNA (miRNA).  Moreover, no 
detectable amounts of the highly abundant 18S and 28S ribosomal RNA (rRNA) were 
detected in the EV preparations indicating an absence of cellular contamination (data not 
shown).  The percentage of EV RNA that was consistent with the size of miRNA (i.e., 
18-24 nucleotides) differed across the follicle size groups with the greatest presence 
(84%) in the 3-5 mm, slightly lower (75%) amounts in 6-9 mm and the least 58 % in the 
> 9 mm diameter follicles (p<0.0001; Suppl Fig II-5B).  The A260/280 and A260/230 
values ranged from 1.56 -1.74 and 0.13 – 0.62, respectively.  
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Figure II- 5 RNA quality and miRNA percentage using the Agilent Small RNA analysis 
protocol.   
A) Isolated RNA from different sized follicles were analyzed using the Agilent Small 
RNA chip. Distribution of different size of RNA was presented as intensity.  The peak at 
4 nucleotide represents the spiked in loading control.  B) Small RNA with the length 
from 18-24 nt were considered as potential miRNA (Agilent protocol) and the percentage 






Three independent small RNA libraries for each of the small, medium and large follicles 
were generated from the follicular fluid EVs.  The total number of reads (Mean ± SEM) 
was 15,144,579 ± 900,792 reads/sample and this ranged from 12,480,394 to 21,361,359 
reads/sample.  Of the total reads for the nine independent pools (3 independent pools / 
size; n=9) 98.333% ± 0.001% mapped to the bovine genome.  Mapping yielded a total 
of 11,770 different identified loci across all samples with the majority of these loci (8360) 
being located in unannotated regions (Figure II-6).  Breakdown of loci falling within an 
annotated region (3410) indicated that 74.8% of these loci were detected within intronic 
regions of genes (2552) with the balance being in protein coding (238) and non-protein 
coding regions (620), which included miRNA (269), snoRNA (67), rRNA (128) and 
others (Figure II-6 shows complete breakdown of RNA subtypes).  The number of read 
counts associated with each of these annotation types varied widely (Table II-2).. While 
only 269 bovine miRNA annotated loci were identified as present in EV RNA, the mean 
read count was 4384 counts/loci indicating that known miRNAs make up a large portion 
(12.2%) of the total number of reads (Table II-2).   
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Figure II- 6 Composite annotation and breakdown of small RNA generated from all 
small, medium and large EV preparations  
(n = 9) following comparison to the annotated bovine genome (assembly UMD3.1, 










Location Count Cumulative Median Mean Std. Err. Max Min
Total number of detected loci 11770 9,629,592 143 818 63 597,958 37
   Loci outside an annotated region 8360 5,207,955 144 623 73 597,958 37
   Loci overlapping an annotated region 3410 4,421,637 140 1,297 125 126,917 38
      Within a gene 2790 1,332,190 134 477 32 43,014 39
         Protein coding 238 40,945 90 172 43 10,255 39
         Intronic region 2552 1,291,245 136 506 34 43,014 41
      Non-protein coding 620 3,089,447 279 4,983 654 126,917 38
         miRNA 269 1,179,225 424 4,384 744 107,513 38
         Pseudogene 6 851 53 142 84 561 42
         snRNA 52 144,802 113 2,785 902 43,559 47
         miscRNA 57 922,140 198 16,178 4,713 126,917 47
         Processed pseudogene 1 86 86 86 0 86 86
         snoRNA 67 15,568 163 232 34 2,255 59
         rRNA 128 812,857 824 6,350 1,585 79,839 63
         Mt-rRNA 30 10,579 193 353 142 4,420 72
         Mt-tRNA 10 3,340 212 334 101 1,114 64
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Following the general alignment to the bovine annotated sequence where we identified 
269 miRNA as present within our samples, we then completed an unbiased approach to 
independently identify known and unknown miRNA within the bovine follicular fluid 
EVs.  Using this unbiased approach we identified 704 loci that met our minimum read 
count requirements of ≥100 reads and the criteria for miRNA annotation within our EV 
samples (Figure II-7A).  Of these 704 loci, 204 were exact matches for known bovine 
miRNAs (Ensemble gene annotation file for bovine; release 70).  Of the remaining 500 
miRNAs, 45 were mapped to a known miRNA of bovine or other species with very 
strong homology in both the mature and hairpin sequence.  Of these 45 loci, 43 fell 
within a miRNA and 2 fell within a miscRNA annotated region in the bovine genome.  
Those 43 loci that fell within a miRNA annotated region, however, differed significantly 
from the previously annotated bovine miRNA. For example, the highly expressed region 
of the mature bta-miR-103 in the current study is 5 bases shorter than the reported bovine 
miRNA in miRBase v21 (Figure II-7B).  Another example, miRNA-224, was also 
shown to differ with respect to its 3’ end (the annotated bovine sequence has 23 bases) 
while the human and murine miR-224 are 21 bases in length (Figure II-7C).   Upon 
closer inspection of the murine sequence (mmu-miR-224) within miRBase, one could 
easily propose that the mouse sequence is 22 bases in length based on the available data.  
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In our study we found that the EVs contained predominantly a 22 base miR-224 and to a 
lesser extent a 24 base version of miR-224 versus the bovine 23 base annotated sequence.  
Another example of a miRNA classification issue is found for a loci between bases 
14462439 and 14462462 of chromosome 3 where a highly expressed mature miRNA like 
sequence aligns to bta-mir-9-5p which is currently annotated (miRBase v21) in two 
different locations within chromosomes 7 and 21, respectively.  While the highly 
expressed mature sequence in the current study is a single base longer than the reported 
bta-mir-9-5p sequence, both its mature and stem-loop regions match exactly with the 
reported miR-9 regions in the four species tupaia chinensis, canis familiaris, pan 
troglodytes and sus scrofa.  Lastly, the current study identified 455 novel miRNA 
sequences that met standard criteria as established in detail in the methods.  Of these 
novel miRNA, 115 fell within and 340 fell outside an annotated feature (e.g., exons, etc.).  
Fig II-8A shows a novel miRNA located in the gene coding for ADAMTS3 whereas the 
other novel miRNA in Fig II-8B is located outside any annotated feature.  We have 
included the putative hairpin structures for all known bovine miRNA, miRNA previously 




Figure II- 7 Annotation breakdown and description of miRNA within the EVs using a 
comprehensive and unbiased approach.  
(A) The flow chart shows the total number of loci and the classification of derivation 
(i.e., known, homologous to other species, and novel) that were associated with sequence 
loci with > 100 read average within a follicle size group that met the Sanger requirements 
to be considered a miRNA (see detailed description in Methods). (B,C) show two 
representative miRNA sequences derived from EVs and compares them to the established 
human and bovine annotated sequences. (B) The current miR-103 sequence is 5 bases 
shorter than the previous annotated bovine and human miR-103 transcripts. (C) The 
current miR-224 sequences were of two lengths 22 and 24 bases (denoted by two 









Figure II- 8 Stem loop structure for two novel miRNA.   
Location, read counts, predicted structure, and read intensity of two novel miRNA, A) 
one located in an annotated region A (ADAMTS3) and B) the other located outside an 







Figure II- 9 The 204 known bovine miRNA are followed by 45 (homologous miRNA) 
and then the list of 455 novel loci that are predicted to encode a miRNA. 
See uploaded files (Navakanitworakul, Hung et al. 2016)  
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Differentially abundant miRNA within EVs of increasing sized follicles 
Comparison of miRNA content within the EVs of small, medium and large follicles 
showed that the greatest differences were observed in the small versus large follicles 
(Table II-3).  Small (3-5 mm) follicle EVs contained 83 miRNA that were more 
abundant in small versus large follicle EVs while 42 miRNA were more abundant in large 
versus small follicle EVs (Table II-3).  Comparison of small to medium follicles 
indicated that 28 EV associated miRNA were more abundant in small and 8 more 
abundant in medium follicle EVs; comparison of medium and large follicles indicated 
that 42 were greater in medium and 17 more abundant in large follicles (Table II-3).  
The breakdown of known bovine miRNA, homologous miRNA and novel miRNA are 
shown in (Table II-3).  The Chi-square test of homogeneity indicates that there is no 
significant difference in the proportion of up-regulated to down-regulated miRNA in the 
three comparisons (Yates’ p-value =0.533).   The relative fold changes in miRNA 





Table II- 3 Distribution of miRNA that differed between small, medium, and large 
follicles* 
 
Comparison S vs L S vs M M vs L 






Bovine 47 33 5 7 24 15 
Other species 
(homologous) 
5 8 2 1 3 2 
Novel 31 1 21 0 15 0 
 All 83 42 28 8 42 17 
*The Chi-square test of homogeneity indicates there is no significant difference in the 
proportion of up-regulated to down-regulated miRNA in the three comparisons (Yates’ p-




As the greatest number of miRNA and the biggest differences were observed for the 
small versus large follicle EV comparison, we have depicted all 80 known differentially 
detected miRNA for this comparison in Table II-4 and all 45 homologous and novel 
miRNA in Table II-5.  For a complete breakdown of each of known and homologous 
miRNA and the novel miRNA that were observed in the different size follicles (see 
Tables II-6 and -7).   Of the differentially present miRNA across follicle sizes, only 8 
known miRNA exhibited changes across all three classification groups.  Five miRNA 
(miR-204, miR-92b, miR-328a-3p, miR-424-3p and miR-450a) exhibited a significant 
progressive increase in read counts as follicle size increased (Table II-6).  Two miRNA 
(miR-19a-3p and miR-335) exhibited a progressive decrease in read counts as follicle 
size increased (Table II-63).  Additionally, 9 novel miRNA were shown to progressively 
decrease in abundance from small to large follicles and none were observed to 




Table II- 4 Normalized read count and fold change of annotated bovine miRNA which 











* All of the following genes were adjusted for multiple tests by the Benjamini and 
Hochberg method and had false discovery rates < 0.05.  Additional details including raw 
counts, exact FDR values, as well as comparisons to medium sized follicles are present in 




 Table II- 5 Normalized read count and fold change of novel and homologous bovine 
miRNA which differed between small and large follicles* 













22:37936196-37936222  (-) 600 892 1.5 
9:72616256-72616283 (+)  821 453 -1.8 
14:4412105-4412134 (+) 2352 1134 -2.1 
4:46639567-46639595 (-) 1853 802 -2.3 
12:89782137-89782164 (+) 1115 428 -2.6 
X:62079641-62079660 (-) 4088 823 -5.0 
X:62078661-62078681 (-) 4286 779 -5.5 
X:144087437-144087455 (+) 1817 320 -5.7 
X:62080685-62080704 (-) 2556 442 -5.8 
X:62081821-62081840 (-) 2820 444 -6.3 
4:113198367-113198384 (-) 1558 209 -7.4 
18:58243447-58243467 (+) 1837 230 -8.0 
13:13589076-13589092 (-) 5226 621 -8.4 
3:63639301-63639326 (-) 8378 696 -12.0 
7:44900586-44900601 (-) 2416 197 -12.2 
11:72567808-72567823 (+) 2415 163 -14.7 
9:103492721-103492748 (-) 2209 118 -18.7 
10:26814520-26814545 (+) 16477 700 -23.5 
16:71150568-71150591 (+) 3630 133 -27.3 
8:89663122-89663138 (-) 8049 238 -33.8 
X:2676228-2676250 (+) 3251 91 -35.3 
21:60864954-60864973 (+) 152167 3229 -47.1 
28:25631928-25631956 (+) 2787 57 -48.0 
20:55442871-55442887 (-) 3718 69 -53.2 
7:20756731-20756752 (+) 1908 32 -58.3 
X:29130246-29130269 (+) 1394 22 -62.1 
9:94314513-94314529 (-) 15284 232 -65.9 
27:27255989-27256011 (+) 2563 37 -69.2 





* All of the following genes were adjusted for multiple tests by the Benjamini and 
Hochberg method and had false discovery rates < 0.05.  Additional details including raw 
counts, exact FDR values, as well as comparisons to medium sized follicles are present in 
Supplemental Table 4.   
7:64776449-64776465 (+) 1825 23 -77.7 
18:22622903-22622918 (+) 67609 671 -100.6 
















181 826 4.57 
11:95709487-95709508 
chi-let-7b-3p 
41 178 4.24 
5:117120245-117120266 
chi-let-7d-3p 
545 2010 3.69 
8:86887492-86887513 
chi-miR-28-3p 
2839 10157 3.58 
1:79250541-79250563 
ssc-miR-1285 
72 231 3.18 
10:42863853-42863882 
chi-miR-361-3p 
167 509 3.05 
X:74328465-74328489 
chi-miR-195-3p 
193 509 2.64 
19:27441353-27441377 
chi-miR-1307-5p 
1281 522 -2.44 
26:24230159-24230179 
eca-miR-199b-3p 
693 211 -3.24 
11:98867681-98867702 
chi-miR-335-3p 
530 154 -3.38 
4:95071042-95071063 
chi-miR-145-3p 
145 36 -3.69 
7:62810788-62810808 
mml-miR-452-3p 




52 7 -5.91 
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Pathway analysis of miRNAs that differed between large and small follicle sizes 
Because the greatest differences existed for the small versus large follicles, we then 
focused our Ingenuity Pathway Analysis (IPA) upon those miRNA. Because of the nature 
of IPA, only miRNA (211) which are annotated in human were used.  MicroRNA that 
were more abundant in small and large follicle EVs were both highly linked to the 
associated Network functions IPA classification called Cancer, Organismal Injury and 
Abnormalies, Reproductive System Disease, which includes miRNA associated with 
reproductive tumors, endometriosis, preeclampsia, and azoospermia (Figure II-10).  
Molecular and cellular function predictions identified cellular development, cellular 
proliferation, cell death and survival and cell cycle as common among those miRNA that 
differed between these follicle sizes (Figure II-10).  MicroRNA that are more abundant 





Figure II- 10 Ingenuity Pathway Analysis predicted functional networks for miRNA 




*Predicted molecular and cellular functions and top networks are depicted.   




In this study we show for the first time that EVs within follicular fluid change in 
number and in their small RNA content when examined across different sizes of follicles.  
Previous work has indicated that small non-coding RNA (i.e., miRNA) exhibit dynamic 
changes during ovarian follicle development (Fitzgerald, George et al. 2016);  we 
discuss several miRNA previously shown to be involved in ovarian function in the 
context of our new observation that they are now also known to be present in follicular 
fluid EVs.  Our study points to the possibility that like hormones, cytokines and 
numerous other factors located within the follicular fluid, EVs also change dynamically 
over time and now must also be considered as a potential mechanism for cell-to-cell 
communication across the antral fluid barrier that spatially separates the cumulus oocyte 
complex from the mural granulosa cells.  Indeed, we have recently shown that EVs from 
small and large follicles can elicit differential effects on cumulus-oocyte-complexes 
(Hung, Christenson et al. 2015). 
In order to fully appreciate whether EVs undergo dynamic changes in the 
developing follicle, the current study took a robust approach to quantify and characterize 
EVs within the follicular fluid of growing bovine follicles.  To confirm the proportion of 
viable healthy to atretic follicles within the pools, an analysis of 20 individually isolated 
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follicles from each size group indicated that a similar proportion of viable healthy to non-
viable atretic follicles (~70 and 30%, respectively).  Moreover, analysis of estrogen and 
progesterone levels in the pools of follicular fluid indicated an increase in estrogen levels 
as the follicle size increased which is typical of healthy growing follicles. Nanoparticle 
tracking analysis (NTA) indicated that the size of EVs is consistent with that attributed to 
the exosomes and small microvesicles.  Interestingly, we observed no change in the 
distribution of particle sizes originating from the different sized follicles.  Importantly, it 
must be pointed out though that our procedure effectively eliminates larger microvesicles 
(>220 um).  Thus, we cannot be absolute in our statement that a population of larger 
microvesicles does not dynamically change during follicular growth. Analysis of the EV 
pellets by electron microscopy further indicated that a relatively homogenous population 
of small vesicles (< 130 nm in diameter) was isolated from the follicular fluid.  
Moreover, and consistent with the NTA, the size and morphology of vesicles by as 
evaluated by electron microscopy were also not different across the three follicle sizes.  
These observations might suggest that EVs are not dynamically changing during follicle 
development.  However, the differential enrichment of CD81 within the EV preparations 
of the small, medium and large follicles suggests that changes within the EV pool are 
occurring.  Conversely, the internal exosomal protein (Alix) was not found to vary in a 
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similar pattern as that of the transmembrane protein CD81 in the EV preps suggesting 
that either the levels of CD81 vary on individual EVs or that different populations of EVs 
exist in different size follicles.  Furthermore, following differential ultracentrifugation, 
the EV pellets were subjected to sucrose gradient centrifugation/fractionation and western 
blot analysis for CD81.  Consistent with an exosomal origin as evident by CD81 
expression (Raposo, Nijman et al. 1996, Valadi, Ekstrom et al. 2007, Simpson, Lim et al. 
2009), we found those fractions with a density of 1.14-1.22 g/ml to be enriched in CD81 
and this was also differentially detected within the three different sizes of follicles.  The 
absence of endoplasmic reticular protein GP96 within the EV prep was further evidence 
of the purity of these preparations (Thery, Regnault et al. 1999).  Ultimately, this 
detailed characterization of the EVs in the current study is reassuring that the subsequent 
next generation sequencing results are originating from a population of EVs within the 
follicular fluid.  The importance of this observation is highlighted by the recent 
observation that serum levels of miRNA are more highly enriched in the non-vesicle 
fractions of serum following ultracentrifugation (Chevillet, Kang et al. 2014).  In 
previous analyses of human and bovine follicular fluid miRNA content, Sang et al. (Sang, 
Yao et al. 2013) and Sohel et al. (Sohel, Hoelker et al. 2013) both detected miRNA within 
the pelleted extracellular vesicle component and in the remaining supernatant.  In both 
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cases the numbers of miRNA identified were greater in vesicular fraction and in the case 
of the bovine study, Sohel et al., (Sohel, Hoelker et al. 2013) suggested that the vesicle-
mediated pathway may be the predominant mechanism of miRNA transport with the 
follicle.  This clearly differs from observations in other bodily fluids (i.e., serum, urine, 
salvia) where it appears that non-vesicular miRNA maybe the predominant form 
(Chevillet, Kang et al. 2014).  Our current study did not address this issue and additional 
studies will be required to determine the relative physiologic importance of these two 
different sources of miRNA within the follicular fluid.    
Our study also shows for the first time that the tetraspanin CD81 exhibits differences 
in levels within the EV preparations of small, medium and large follicles.  This protein 
belongs to a large family of tetraspanin proteins that are found in numerous cell types 
(Caplan, Kamsteeg et al. 2007) and are enriched in exosomes (Valadi, Ekstrom et al. 
2007, Simpson, Lim et al. 2009).  Previous studies demonstrated that CD81 was highly 
expressed by murine cumulus cells which surround oocytes (Tanigawa, Miyamoto et al. 
2008) and by periovulatory bovine mural granulosa cells (Christenson, Gunewardena et 
al. 2013) before and after the LH surge.  Immunohistochemistry indicated that the zona 
pellucida surrounding mouse oocytes was highly enriched in CD81 (Ohnami, Nakamura 
et al. 2012).  A role for CD81 in murine ovarian function was demonstrated when 
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targeted deletion of the gene caused female mice to exhibit a 40% reduction in fertility 
(Rubinstein, Ziyyat et al. 2006).  Further studies showed that this loss in fertility was 
due to the inability of oocyte to fuse with sperm (Rubinstein, Ziyyat et al. 2006).  
Interestingly, the source of the zona pellucida CD81 does not appear to be of oocyte 
origin as CD81 was not detected in the oocyte and furthermore oocytes microinjected 
with exogenous CD81 mRNA failed to produce CD81 or reverse the sperm fusion defect 
(Ohnami, Nakamura et al. 2012).  In our study, the highest level of CD81 was found in 
EVs derived from 3-5 mm diameter follicles while the level of CD81 decreased in EVs 
from 6-9 mm and > 9 mm follicles.  The biological meaning of this change in CD81 
within the EVs isolated from the different size follicles as well as the source of the CD81, 
i.e., whether it is of serum or granulosa/cumulus derivation requires further investigation.   
In our evaluation of RNA within the EVs, the preponderance of small RNA species 
ranged in size from 20 to 40 nucleotides in length, consistent with these small RNA 
species being of a size consistent with miRNA.  Our sequencing results indicated that 
12.2% of small RNAs were of miRNA origin which is consistent with that observed 
(15.4%) in the only other small RNAseq results for follicular fluid (Sang, Yao et al. 
2013).  In addition to the overall abundance of miRNA (43.3% of the total of non-
protein coding loci), several other small RNA species were identified within EVs 
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including snRNA (8.3%), snoRNA (10.8%), rRNA (20.6%), miscRNA (9.2%).  The 
presence of miRNA within EVs was previously documented in equine (da Silveira, 
Veeramachaneni et al. 2012), bovine (Sohel, Hoelker et al. 2013), and human (Sang, Yao 
et al. 2013, Diez-Fraile, Lammens et al. 2014, Santonocito, Vento et al. 2014) follicular 
fluid.  In the bovine and equine studies, EVs were isolated using the ExoQuick 
precipitation method followed by qPCR arrays to identify miRNA.  Recently it was 
shown that the Exoquick precipitation method generates a greater range of vesicle sizes 
and increased protein contamination when compared to the standard differential 
ultracentrifugation method used here (Santonocito, Vento et al. 2014).  Additionally, 
these studies evaluated miRNA abundance using qPCR arrays designed for detection of 
human miRNA, which limits their observations to those miRNA with 100% homology to 
the human sequence.  It should be noted though that many miRNA are 100% homologus 
with respect to the mature miRNA sequence across a large number of species (Griffiths-
Jones, Saini et al. 2008).  However, consistent with our observation of a large number of 
miRNA within the bovine follicular fluid, Sohel et al., (Sohel, Hoelker et al. 2013) 
observed 509 different miRNA in bovine follicular fluid isolated from 4-8 mm follicles.  
Using our unbiased small RNAseq approach, we detected the presence of 249 previously 
known miRNA (bovine or other species annotated) and the presence of 455 previously 
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unknown miRNA in bovine EVs.  The large number (455) of novel miRNA found 
within bovine follicular fluid could indicate that this bodily fluid is exceptionally 
enriched in miRNA or could be a reflection of the incomplete annotation of miRNA 
species within the bovine.  Currently, the bovine has 682 unique annotated miRNA and 
of these 36.5% were identified within our follicular fluid EVs.  In addition to large 
numbers of novel miRNA, a number of miRNA (45) identified in the bovine EVs, not yet 
annotated in the bovine genome, were consistent with previously identified miRNA in 
other species.  Recently, Maalouf et al., (Maalouf, Liu et al. 2014) in a small RNAseq 
analysis of bovine corpora lutea, identified 590 miRNA of which 46 were novel miRNA.  
This large difference in numbers of novel miRNA between our study and theirs is likely 
due to their restriction of identification of novel miRNAs to only regions within introns 
or antisense exon regions, a criteria we chose not to employ in our current study.  
Additionally, several novel miRNA structures identified in the current study were found 
replicated identically or nearly identically in both stem-loop and mature sequence in 
different locations across the genome; we considered each as a different putative novel 
miRNA.  Recent analysis of miRNA sequences in 13 different human cell lines 
indicated the presence of a substantial number (3707) of previously unidentified 
microRNA (Londin, Loher et al. 2015).  Follicular fluid EVs appear to be a rich source 
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of miRNA.   
      This study is the first to examine the differential abundance of miRNA within 
EVs across different stages of follicular growth. Previous studies have evaluated 
follicular fluid derived EVs isolated from follicles of young and old mares (da Silveira, 
Veeramachaneni et al. 2012), women with and without polycystic ovarian syndrome 
(Sang, Yao et al. 2013), IVF patients (Santonocito, Vento et al. 2014), and in young (age 
31) versus old (age 38) IVF patients.  In the previous bovine experiment, follicles within 
a single range of size 4-8 mm were classified based on oocyte brilliant cresyl blue 
staining which can define the oocyte as growing or fully grown (Sohel, Hoelker et al. 
2013). Unfortunately, comparisons across these two studies are not possible based on the 
divergent experimental designs, methods of exosome isolation and miRNA identification 
methods.  Not surprisingly, comparison of the miRNAs within the EVs of large (>9 mm) 
versus small (3-5 mm) follicles showed the greatest difference in number of differentially 
present miRNA, with 42 increased and 83 decreased.  Changes in miRNA from small to 
medium and medium to large follicle EVs were intermediate as might also be expected. 
Five miRNAs exhibited significantly progressive increases in read counts as follicle size 
increased including miR-204, miR-92b, and miR-328a-3p, miR-424-3p and miR-450a.  
Mir-204 has been addressed as a cell proliferation inhibitor in several cell types (Shi, 
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Huang et al. 2015, Wu, Pan et al. 2015, Wu, Zeng et al. 2015, Wu, Wang et al. 2015, Xia, 
Liu et al. 2015, Yin, Liang et al. 2015), this could be possibly linked to the decrease in 
cell proliferation that occurs with increasing follicle size.  MiR-92b was more abundant 
in large follicle than small follicle EVs.  Significant changes in miR-92b expression 
levels have also been noted in the process of neointimal formation in a rat model of 
vascular injury (Ji, Cheng et al. 2007), in individuals with a cardiac rehabilitation 
following surgical coronary revascularization (Taurino, Miller et al. 2010) and in 
individuals with heart failure (Goren, Kushnir et al. 2012), indicating that miR-92 is also 
involved in neovascularization.  However, the function of miR-92b in reproduction is 
still unknown.  DNA methyltransferase 3a (Dnmt3a) is known as a target of miR-450a 
and ectopic miR-450a expression in HepG2 cells decreased Dnmt3a and blocked 
inhibition of cell proliferation (Weng, Wang et al. 2011).  The roles of miR-328a-3p and 
miR-424-3p are currently poorly described.  Conversely, levels of miR-19a-3p and miR-
335 exhibited significant progressive decreases as follicle size increased. Mir-19a-3p has 
been reported to inhibit breast cancer progression (Yang, Zhang et al. 2014).  Deletion 
of miR-335 is a common event in human breast cancer and also correlates with ovarian 
cancer recurrence (Png, Yoshida et al. 2011).  Others showed that the level of miR-335 
is highly elevated in astrocytoma cells and human malignant astrocytoma suggesting that 
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miR-335 might be a tumor promoter by promoting tumorigenic features such as growth 
and invasion of malignant astrocytoma (Shu, Zheng et al. 2011).  Our bioinformatics 
analyses of pathways also pointed to the changes in vascularization, as evident by the 
significant association of the different miRNA observed in the small versus large follicle 
EVs and the inflammatory pathway.  Interestingly, miR-150 which exhibited the most 
profound difference in small versus large follicles (Table II-2) was previously reported as 
an oncomiR because of its promotional effect on vascular endothelial growth factor 
(VEGF) (Liu, Zhou et al. 2004). During tumor development, tumor-associated 
macrophages (TAMs) secrete VEGF and other factors to promote angiogenesis. MiR-150 
targets TAMs to up-regulate their secretion of VEGF in vitro. Angiogenesis is known to 
increase dramatically during development of follicle with a pronounced increase 
following selection of the dominant follicle (Beg and Ginther 2006).  Human follicular 
fluid contains elevated VEGF production following induction by the surge of LH in in 
vitro fertilization patients (Anasti, Kalantaridou et al. 1998). Thus, miR-150, which was 
more abundant in the large follicle, might also be involved in the vascular development, 
follicle growth, and the ovulation of oocyte through its regulation of VEGF.   
The importance of miRNA in the ovary has been illustrated in clinical studies and studies 
where key elements of the miRNA biogenetic pathway or where specific miRNA have 
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been genetically deleted.   Loss of Dicer, the key enzyme of miRNA biogenesis, results 
in decreased fertility and ovulation rate were observed (Otsuka, Jing et al. 2007, Hong, 
Luense et al. 2008, Otsuka, Zheng et al. 2008). The change of follicular extracellular 
associated miRNA was also demonstrated in polycystic ovarian syndrome (Sang, Yao et 
al. 2013, Roth, McCallie et al. 2014). miR-224 which discussed above is known 
expressed higher in preantral follicle and is able to regulate estradiol production (Yao, 
Yin et al. 2010). miR-378 which decreased 2.4 fold from small to large antral follicle in 
our result was also reported to decrease during antral follicle growth and has the ability to 
regulate Cyp19A1, critical gene for estradiol production. 
 Taken together, the results of the present study demonstrate for the first time that 
EVs differ in number, presence of protein markers and miRNA contents as follicle size 
changes. Specifically, CD81, one of three major marker proteins used for exosome 
identification, exhibited decreased abundance as follicle size increased suggesting that 
changes in EV biogenesis or uptake is occurring during follicle maturation/development.  
Functional analyses of individual miRNA that are associated with changes in follicle 
development also await further study, yet the current study provides clear and robust data 
regarding which miRNA might be first to be evaluated.  This in combination with the 
recent observations that follicular fluid EVs are biologically functional (induce cumulus 
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expansion and gene expression) and differ in their functional activity based on the size of 
follicle they were derived from is consistent with our current observations.  
Cumulatively, the observations point to the potential for a unique EV signaling 











IX. Chapter III: Extracellular vesicles from bovine follicular fluid 




 Antral follicles in the mammalian ovary enlarge with the secretion of follicular fluid 
that fills the growing cavity between the layers of granulosa cells (Rodgers and Irving-
Rodgers 2010).  This viscous fluid is a complex solution containing a mixture of water, 
electrolytes, proteins, RNA, and extracellular vesicles providing a route for autocrine and 
paracrine communication between theca, mural granulosa, and cumulus cells and the 
maturing oocyte (Gosden, Hunter et al. 1988).  The content of follicular fluid correlates 
with the stage of the follicular growth and the developmental potential of the oocyte 
(Revelli, Delle Piane et al. 2009, Sohel, Hoelker et al. 2013).   
 Extracellular vesicles (EVs) such as exosomes and microvesicles (ectosomes) have 
been identified in follicular fluid in several mammalian species including human, bovine 
and equine (da Silveira, Veeramachaneni et al. 2012, Sang, Yao et al. 2013, Sohel, 
Hoelker et al. 2013, Diez-Fraile, Lammens et al. 2014).  Studies of cancer cell lines, 
have demonstrated that cargos such as proteins and RNA within EVs can influence 
behavior and gene expression of cells both near and far (Vlassov, Magdaleno et al. 2012, 
Cocucci and Meldolesi 2015).  Formation of EVs occurs either by budding from the cell 
surface (microvesicles) or release from multivesicular bodies (exosomes) following 
fusion with the plasma membrane (Cocucci and Meldolesi 2015).  The size range of 
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these two distinct types of EVs overlaps with exosomes ranging from 30-200 nm in 
diameter and microvesicles typically considered to range from 50-1,000 nm (Gyorgy, 
Szabo et al. 2011).  EVs are characterized by the presence of specific membrane 
associated proteins, which are enriched in the EVs as compared to intact cells.  These 
markers include several tetraspanins, CD81, CD63 and CD9 as well as other proteins, 
such as Alix, a protein involved in endosomal transport and tumor suppressor gene 101 
(Tsg101) and others (Bissig and Gruenberg 2014, Kumar, Gupta et al. 2014).  Follicular 
fluid EVs have been associated with varying protein and RNA cargos depending on such 
factors as a woman’s age (Diez-Fraile, Lammens et al. 2014) or the presence of ovarian 
pathologies such as polycystic ovarian syndrome (Sang, Yao et al. 2013).  Follicular 
fluid EVs carry microRNA (miRNA) and can be taken-up by cultured granulosa cells (da 
Silveira, Veeramachaneni et al. 2012, Sohel, Hoelker et al. 2013) demonstrating that they 
could potentially act as a method for cell-to-cell communication within the antral follicle.     
 Communication between mural granulosa and the cumulus oocyte complex (COC) 
is known to occur bi-directionally across the antral follicular fluid (Su, Sugiura et al. 
2010, Conti, Hsieh et al. 2012).  As an example, the LH surge stimulates release of 
mural granulosa EGF-ligands that must then traverse the follicular fluid to affect the 
cumulus cells in order to induce the characteristic gene expression changes and expansion 
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of the COC(Su, Sugiura et al. 2010, Conti, Hsieh et al. 2012).  The precise mechanism 
by which these and other signaling molecules move through the follicular fluid to rapidly 
affect cumulus cells remains unknown.   
Transmission of signals through an EV-mediated system is a possible mechanism 
of signal transduction within the follicle.  In cancer cell models, EVs released into the 
microenvironment can increase cell motility and cause rapid modifications to the 
extracellular matrix (Mu, Rana et al. 2013, Webber, Yeung et al. 2015).  Similarly, 
cumulus expansion in response to the LH surge involves increased cumulus cell motility 
(Akison, Alvino et al. 2012, Kawashima, Liu et al. 2012), and rapid secretion of a 
hyaluronan-enriched extracellular matrix (Russell and Salustri 2006, Kimura, Hoshino et 
al. 2007).  While the cargos carried by follicular EVs varies greatly under different 
physiologic states, no direct effects of EVs on ovarian physiology have been 
demonstrated to date.   The objective of the present study was to determine whether 
follicular EVs could affect the morphology and gene expression of cumulus cells during 
COC maturation.   
METHODS 
COC collection 
 COC were collected from CF1 female mice (21-24 days old obtained from Harlan 
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Sprague-Dawley, Indianapolis IN USA or Charles River Labs, Wilmington MA USA).  
Mice were housed in a temperature and light-controlled room on a 14L:10D light cycle 
and experiments were conducted in accordance with NIH guidelines for the Care and Use 
of Laboratory Animals and approved by the University of Kansas Medical Center Internal 
Animal Care and Use Committee (IACUC). To stimulate synchronous follicular 
development, mice were administered 5 IU of equine chorionic gonadotropin IP (eCG; 
Calbiochem, San Diego CA USA). Mice were euthanized by isoflurane inhalation 
anesthesia followed by cervical dislocation.  Ovaries were collected at 44-46 hr post-
eCG and COC were released from large antral follicles by rupturing the follicles with a 
sterile needle into HEPES-buffered KSOM medium (Biggers and McGinnis 2001) 
supplemented with 4 mg/ml polyvinyl alcohol (PVA; and containing no bovine serum 
albumin (BSA) or fetal bovine serum (FBS)).  Pools of COC were created from 5-10 
females, and only COC that contained a GV stage oocyte (~>75 μm) surrounded by 2 or 
more intact layers of cumulus cells were selected for culture.  COC containing dark, 
small or non-GV oocytes, or discontinuous cumulus layers were discarded.  Unless 
otherwise stated, all chemicals and reagents were purchased from Sigma Chemical 




Murine COC culture 
 Sets of 3-5 COC were transferred to KSOMaa (Evolve; Zenith Biotech, Guilford CT 
USA) supplemented with 4 mg/ml polyvinyl alcohol (10,000 mw; no BSA) with or 
without FBS and/or follicular EVs (100 μg protein/ml) according to the individual 
experimental protocol (see results for details of each treatment).  Follicular fluid EV 
levels approximated 80-120 μg protein/ml and preliminary dose response studies 
indicated that 100 μg/ml dose of follicular EVs yielded consistent responses in mouse 
COC assays.  Mouse COC were cultured for 16 hr in 20 μl drops of media under oil in 
35 mm petri dishes (NUNC from Thermo Scientific, Rochester NY USA) at 37.2℃ in an 
incubator with 6% CO2 in humidified air.  Each dish contained 3-5 culture drops of 
COC and each treatment was cultured in a separate dish to ensure no passage of treatment 
factors between drops of COC.  The number of COC in each drop was determined on 
the day of culture according to the total number of COC collected on that day and all 
drops cultured on that day contained the same number of COC.  COC collected each day 
were randomly distributed across all treatments. 
 
Bovine follicular fluid and COC collection 
Cow ovaries were obtained from a local abattoir in Omaha, Nebraska.  Ovaries were 
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transported to the University of Kansas Medical Center in phosphate buffered saline 
(PBS) at room temperature in preparation for ovarian follicular fluid aspiration.  
Ovarian follicular fluid was collected by needle aspiration from follicles with diameters 
of 3-5 mm (small) and > 9 mm (large) antral follicles. Four independent collections of 
follicular fluid were conducted in a two-month period.  Follicular fluids from small and 
large antral follicles were pooled on each collection day.  All COC were collected by 
pulled glass pipet and transferred to 400 μl of warm HEPES-buffered TCM199.  High 
quality COC from the small antral follicles were used for COC cultures in TCM199 
media using the same supplements and culture set-up protocol as described for the mouse 
except that bovine COC were matured for 24 hr at 39℃ and always in sets of 3 
COC/drop with or without follicular EVs (200 μg protein/ml).  Since very few COC (3-
5/collection day) were found in follicular fluid from large follicles, none of the COC from 
large follicles were used in the culture experiments.   
Follicular EV isolation by differential ultracentrifugation 
Follicular EVs isolated from 15 ml of ovarian follicular fluid were obtained via a series 
of differential ultracentrifugation steps as described in (Thery, Amigorena et al. 2006).  
Follicular fluid was diluted with an equal volume of PBS prior to centrifugation.  To 
eliminate residual granulosa cells and oocytes, samples were spun at 800 g for 10 min 
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followed by 2000 g for 20 min.  Fluid was then centrifuged at 12000 g for 45 min to 
remove cell debris and large particles.  The samples were then filtered through a 0.22 
μm pore filter to remove particles larger than 200 nm.  Ultracentrifugation was 
performed at 110,000 g for 3 hr in a Beckman X100 ultracentrifuge, using a swinging 
bucket SW32Ti rotor, to pellet the follicular EVs. The pellets were then washed twice in 
PBS by centrifuging at 110,000 g for 1.5 hr.  All centrifugations were performed at 4°C.  
The obtained pellets were re-suspended in PBS for further analysis.  For EVs staining, 
EVs were stained with PKH67 Green Fluorescent Cell Linker Kit (Sigma Chemical Corp, 
St Louis MO USA) per manual protocol and pelleted by ultracentrifugation following 
several washes in PBS before final resuspension in PBS. 
Nanoparticle tracking analysis 
To determine particle size and concentration within follicular fluid from follicles of 
varying sizes, nanoparticle tracking analysis (NTA) was performed with a NanoSight 
LM10 instrument (Malvern Instruments, Worcestershire UK).  Follicular EV 
preparations were diluted first in PBS to meet the optimal concentration between 105-108 
particles/ml.  At least 300 μl of diluted sample was needed for each analysis and was 
mixed by vortexing before injection into the chamber. Three individual videos were 
collected and the resulting counts were averaged for each diluted sample.  Triplicates of 
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the same dilution were performed and the overall average of these dilutions were used as 
the experimental result for each sample.  Each video of moving particles was 60 s in 
duration, with a shutter speed of 30 ms and camera gain of 680.  Software settings for 
analysis were: Detection threshold: 6, Blur: auto, Minimum expected particle size: 50 
nm.  A minimum of 200 completed particle tracks were completed for each video and 
the data was analyzed using the NTA 2.3 analytical software (Malvern Inc.).  Data are 
presented as the average and standard deviation of the triplicate. 
Western blot Analysis 
EV samples (10 μg protein) were lysed in SDS sample buffer with 50 mM DTT, heated 
for 5 min at 95 °C and subjected to electrophoresis using 12% SDS-PAGE in running 
buffer at constant 120 V for 1.5 hrs. Proteins were then electrotransferred onto 
polyvinylidenedifluoride membranes, and the membranes were blocked with 5 % (w/v) 
skim milk powder in Tris-buffered saline with 0.05 % (v/v) Tween-20 (TTBS) for 1 h at 
RT. Membranes were then probed with primary anti-CD81 (sc-166029) and anti-Actin 
(sc-1616) antibodies for 1 h in TTBS (50 mM Tris, 150 mM NaCl, 0.05 % Tween20) 
followed by incubation with the secondary anti-mouse IgG or anti-sheep goat antibodies 
for 1 h. All primary antibodies were purchased from Santa Cruz Biotechnology Inc. 
Membranes were washed three times in TTBS for 10 min after each incubation step and 
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detected by enhanced chemiluminescence (ECL) (GE Healthcare Bio-science, PA) per 
manufacturer’s instructions. 
Nomarsky live microscopy 
 All COC were imaged by Nomarsky optics on a Nikon TE200 or DIC on an 
Olympus IX71 inverted microscope immediately after transfer to culture drops and again 
after 16 hr (murine) or 24 hr (bovine) of maturation.  Images were captured with 110x 
UplanFl 0.30 Ph1 and 20x LCplanFl 0.40 Ph1 objectives and Olympus DP71 camera.  
The diameter of each murine COC was measured using ImageJ software (Schneider, 
Rasband et al. 2012).  For each COC, two diameters were measured then averaged, 
resulting in an average diameter.  The overall measure of expansion was the average 
change from 0 hr (start of culture) to 16 hr for all COC within each drop.   
Transmission electron microscopy 
EVs (10 mg/ml) were fixed overnight (2% glutaraldehyde and 0.1 M cacodylate 
buffer) and washed with 0.1 M sodium cacodylate buffer. The pellet was post-fixed in 1% 
osmium tetroxide with 1% potassium ferric cyanide buffered in 0.1 M cacodylate buffer 
for 1 hr. A glow discharge treated carbon film 300 mesh grid was inverted and floated 
upside down on the drop containing fixed EVs (20 min).  Each grid was rinsed 7x with 
filtered distilled water then stained with 1% uranyl acetate.  All samples are examined in 
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a JEOL-JEM-1400 transmission electron microscope at an 80-100 kV with 25,000x 
magnification.   
RNA isolation and quantitative RT-PCR analysis 
RNA was isolated using the Arcturus PicoPure RNA Isolation kit (Life 
Technologies, Carlsbad CA USA), with an on-column DNase I digestion. Concentration 
and purity of RNA were determined by using the Agilent RNA 6000 Pico kit (Agilent 
Technologies, Palo Alto CA USA) and Bioanalyzer (Agilent Technologies, Santa Clara 
CA USA).  Total RNA was reverse-transcribed using SuperScriptTM II Reverse 
Transcriptase (Life Technologies) with random primer per manufacturer’s instruction.  
Quantitative PCR was then performed with 1:5 dilution of cDNA on an Applied 
Biosystems HT7900 sequence detector.  Primer sets for mouse Ptgs2 (forward: TGA 
CCC CCA AGG CTC AAA TA, reverse: CCC AGG TCC TCG CTT ATG ATC), Ptx3 
(forward: CCC GCA GGT TGT GAA ACA G, reverse: TGC ACG CTT CCA AAA ATC 
TTC), Tnfaip6 (forward: ATA CAA GCT CAC CTA CGC CGA, reverse: ATC CAT CCA 
GCA GCA CAG ACA T), bovine Ptgs2 (forward: TGG GTG TGA AAG GGA GGA AA, 
reverse: GTG AAA GCT GGT CCT CGT TC), Ptx3 (forward: CCG GCA GGT TGT 
GAA ACA G, reverse: CAG CGA CCA GTC TGT TTT CC), Tnfaip6 (forward: AAC 
CCA CAT GCA AAG GAG TG, reverse: GCC GTG GAC ATC ATC GTA AC) and U6 
111 
 
(forward: CTC GCT TCG GCA GCA CA, reverse: AAC GCT TCA CGA ATT TGC GT) 
were designed using Primer Express 3.0 software (Applied Biosystems) and GAPDH 
primers and probe were purchased from Life Technologies.  Samples were run in 
triplicate, and the ΔΔCt method was used to calculate the relative fold change between 
the samples after normalization with GAPDH or U6 for mouse or bovine COC, 
respectively. The presence of a single dissociation curve confirmed the amplification of a 
single transcript and lack of primer dimers. 
Statistics 
 Results of multiple repeats were presented as means ± SEM. A one-way analysis 
of variance (ANOVA) followed by Newman-Keul multiple comparison test was used to 
determine statistical differences between groups.  Bartlett’s test was included to ensure 
equal variance in the group.  If the data did not follow a normal distribution, the data 
sets were log transformed before performing the statistical analyses.  
RESULTS 
Characterization of follicular EVs 
 To confirm that follicular EVs were present in our isolates, we used a combination 
of techniques.  Electron microscopy revealed a heterogeneously sized population of 
circular vesicles, 50-200 nm in diameter (Fig III-1A from small antral follicles; Fig III-1B 
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from large antral follicles), many with the characteristic concave centers that result from 
the collapsing of the EV upon drying on the film (Fig III-1*) .  The purity of the 
follicular EV preparation was confirmed as few protein conglomerates were observed 
(dense/dark objects).  We further characterized the follicular EVs from small and large 
follicles using nanoparticle tracking analysis (Fig III-1C).  Follicular EVs ranged in size 
between ~30 to 325 nm with an average size of 142 and 128 nm for EV from small and 
large, respectively. CD81, an established exosome marker, was used to confirm the 
presence and enrichment of exosomes in the EV preparations.  We found that CD81 was 




Figure III- 1 Characterization of follicular EVs from bovine follicular fluid.   
After centrifugation and washing isolated follicular EVs were examined by negative 
staining on an electron microscope to determine the presence and characteristics of the 
follicular EVs. Both small (A) and large (B) antral follicles contained EVs of varying 
sizes, mostly spherical and some with the concave centers that are characteristic of 
exosomes (*).  (C) Nanoparticle tracking analysis (NTA) indicates that EVs collected 
from small and large follicles are similar in size.  NTA was repeated on three isolates of 
follicular EVs collected on different days and are overlaid in this figure to graphically 
demonstrate the variation between these follicular EV isolates. The average diameters 
(nm) of particles are shown for each of the three independent preparations of small and 






Uptake of follicular EVs by cumulus cells  
To determine if bovine follicular EVs are taken up by mouse cumulus cells, 
PKH67-labeled follicular EVs were cultured with COC for 16 hr.  Green fluorescent 
punctate spots (internalized EVs) were observed in the cytoplasm of cumulus cells and 
localized near the nucleus (Fig. III-2).  Follicular EVs were detected in all layers of the 
expanded cumulus including those cells farthest from the oocyte (Fig. III-2A) as well as 
those cells next to the zona pellucida (i.e., corona radiata; Fig. III-2C).  To ensure that 
nonspecific staining of cells from leftover dye was not occurring, we also cultured COC 
with the supernatant from the last wash, no staining was detected (Fig. III-2B).  We also 
did not detect uptake of follicular EVs by the oocytes of intact COC although we did 
observe evidence of EVs associated with the transzonal processes, which span the zona 




Figure III- 2 Cumulus cells uptake follicular fluid EVs during COC culture.  
Mouse COC were cultured 16 hr with PKH67 labeled bovine follicular EVs.  Individual 
COC were imaged in serial z-sections on a Zeiss Pascal confocal microscope (40x) and 
examined for internalization of follicular EVs.  In the expanded COC, internalized 
follicular EVs are evident as green spots within cumulus cells both in the outer layer of 
cumulus cells (A) and in cumulus cells located adjacent (C) to the oocyte (o=oocyte).  
To insure that the COC labeling was result of EV uptake, the final wash of the follicular 
EVs PKH67 labeling process was added to COCs and cumulus cells were all negative for 
PKH67 (B).  Distance between serial z-stack A and C was 30 μm within the same COC.  
A’ and C’ are same as A and C but with DIC turned off.  A’’ and C’’ are enlargements 






Follicular EVs induce cumulus expansion 
To determine if follicular EVs have a physical effect on the expansion of the 
COC, we in vitro matured mouse COC with or without the addition of bovine follicular 
EVs (Fig III-3).  Differential interference contrast (Nomarski) imaging was used to 
determine the diameter of COC at the beginning (0 hr) and at the completion of the 16 hr 
mouse IVM protocol.  The COC cultured without serum (PVA only control) did not 
expand during culture (negative control; Fig III-3A).  Addition of 10% FBS (positive 
control) caused an increase in the diameter of the COC (cumulus expansion; Fig III-3B).  
Similar, to the positive control, follicular EVs from both small (3-5 mm) and large (>9 
mm) bovine antral follicles induced cumulus expansion (Fig III-3C, 3D).  Analysis of 
changes in COC diameter (percentage) confirmed that follicular EVs from both small and 
large antral follicles could induce cumulus expansion significantly greater than occurred 
in medium alone (i.e., negative control; Fig III-3E).  Paradoxically, EVs isolated from 
small antral follicles exhibited a greater effect on cumulus expansion than those isolated 
from larger preovulatory follicles when cultured without FBS.  To determine if the 
observed effects of follicular EVs was due to contaminants of EV from blood serum, we 
next tested COC expansion in media which contained 10% FBS plus follicular EVs. The 
follicular EVs from both small and large follicles increased cumulus expansion over that 
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observed for COC cultured with FBS (EV containing) alone, indicating that follicular 
EVs had an additive effect over any possible effects of FBS EVs (Fig III-3F).  Since 
whole serum such as FBS contains endogenous EVs we also cultured COC with either 
whole FBS or FBS that was processed by ultra-centrifugation and filtration to remove 
endogenous EVs (EV-free FBS; EF-FBS).  In these experiments there was no difference 
between FBS with or without the native serum EVs (Fig III-3G).  These results indicate 
that cumulus expansion in response to EV from antral follicles is specific to follicular 
EVs and not a general of effect EVs from serum.  
Next, we evaluated whether the effects of bovine follicular EVs on mouse COC 
could be duplicated using bovine follicular EVs on bovine COC.  Consistent with the 
mixed species experiments using bovine EVs with mouse COC, bovine follicular EVs 





Figure III- 3 Bovine follicular EVs induce mouse cumulus cell expansion.   
Mouse COC were matured with follicular EVs from either small or large antral bovine 
follicles.  COC were imaged by DIC at the beginning of culture (0 hr) and end (16 hr).  
Negative control COC cultured with no FBS and with no follicular EVs did not expand 
(A).  COC cultured with either FBS (B; positive controls), or with follicular EVs from 
small antral (C) or large antral (D) follicles induced cumulus expansion.  Cumulus 
expansion was quantified and the percent change in diameter of the COCs after 16 hr of 
in vitro maturation is shown.  Panel E - COCs cultured with no serum or EV exhibited 
very little expansion.  In the absence of serum, cumulus expansion induced by follicular 
EVs from the large antral follicles was significantly less than that induced by small antral 
follicle EVs (A).   Panel F - COC matured with follicular EVs added to media 
containing FBS.  COC cultured in FBS exhibited some expansion and follicular EVs 
increased cumulus expansion over that of whole FBS (i.e., FBS containing endogenous 
EVs).   Panel G – COC matured in whole FBS, extracellular vesicle-free FBS (EV-
FBS), with and without follicular EVs from small or large follicles.   Removing serum 
endogenous EVs from the FBS had no effect on cumulus expansion, while addition of 
follicular EVs still significantly increased COC expansion (C).   a, b, cMeans ±SEM with 






Figure III- 4 Bovine follicular EVs induce cumulus expansion of bovine COC.   
Bovine COC were matured with follicular EVs from either small or large antral bovine 
follicles.  COC were imaged by DIC at the beginning of culture (0 hr) and following in 
vitro maturation (24 hr).  Negative control COC cultured with no FBS and with no 
follicular EVs did not expand (A).  COC cultured with either small follicle EVs (B), or 






Analysis of COC expansion marker genes 
To determine if follicular EVs affect the expression of genes associated with 
cumulus expansion, we examined the expression of three genes with known functions in 
COC expansion: Ptgs2, Ptx3 and Tnfaisp6.  Treatment of mouse COC with bovine 
follicular EVs from small antral follicles significantly increased expression of Ptgs2 and 
Ptx3 with the fold change of 2.7 and 20.3, respectively (Fig III-5A).  There was also a 
trend for increased expression of Tnfaisp6 (average fold change of 3.5) although this 
change did not reach significance (P<0.08).  Bovine COC matured with bovine 
follicular EVs from small antral follicles also significantly up regulated expression of 
Ptgs2 (7.1 fold), Ptx3 (5.1 fold) and Tnfaip6 (7.5 fold; Fig III-5B). Follicular EVs from 
large antral follicles did not induce the expression of Ptx3 or Tnfaip6, however, there was 
a decrease in the expression of Ptgs2 in mouse COC.  
125 
 
Figure III- 5 Follicular fluid EVs induce genes involved in cumulus expansion.   
COC from mice (A) and cows (B) were matured for 16 hr and 24 hr, respectively, 
followed by quantitative RT-PCR analysis of Ptgs2, Ptx3 and Tnfaip6 levels.  Small 
follicle EVs increased cumulus gene expression in both mouse (A) and bovine COC (B), 
while large follicle EVs did not.  Mouse COC Tnfaip6 expression trended (p= 0.08) to 
increase.   a, bMeans ±SEM with different superscripts are significantly different 








Ovarian follicular fluid is enriched with proteins, RNA, and extracellular vesicles.  
Our studies have demonstrated for the first time that follicular EVs can impact ovarian 
function.  Follicular EVs were able to modify cumulus gene expression and to support 
cumulus expansion.  Interestingly, follicular EVs isolated from small antral follicles 
exhibited more activity than those from large follicles (Fig. III-3), even though in vivo, 
COC from small follicles do not undergo expansion.  However, when bovine COC from 
small antral follicles are released into culture they are functionally capable to undergo 
expansion (Fig III-4). And, similar to the murine COC, the bovine COC exhibited 
significant increased gene expression when exposed to EV from small but not large antral 
follicles (Fig. III-5A and 5B).  This is an interesting phenomenon, which is discussed 
below and poses many questions for examination in future studies.   
Mammalian COC secrete a hyaluronan-enriched extracellular matrix that 
separates the cumulus cells and the oocyte leading to what is termed cumulus expansion 
in response to the LH surge.  LH receptors are found primarily in the theca and mural 
granulosa of antral follicles but not in the early cumulus cells.  It is theorized that 
cumulus expansion is triggered in vivo in response to signals that are generated first by 
the mural granulosa cells and transmitted through the follicular fluid to affect the cumulus 
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cells.  Indeed, many studies support a model by which EGF ligands; such as 
amphiregulin, epiregulin and epigen are released from mural granulosa cells to 
subsequently effect the cumulus cell gene expression and expansion (Carletti and 
Christenson 2009, Conti 2010).  Whether these growth factors are simply released into 
the follicular fluid and work in a juxtacrine manner down a concentration gradient, or 
whether they are also partially released as a constituent of EVs is currently unknown.  
Interestingly, EGF-ligands and active receptors (ErbB1) have been detected in EVs 
released from cancer cells (Sanderson, Keller et al. 2008).  While we did not detect any 
EGF-ligands in the follicular fluid EVs, the negative results may be partially due to 
problems with antibody specificity to the bovine molecules (data not shown).  RNAseq, 
proteomic and lipidomic studies that can unbiasedly identify follicular EV RNAs, 
proteins and phospholipids are underway in our laboratory to address this question.  The 
fact that small follicle EVs exhibited the greatest increase in cumulus expansion however 
argues against an EGF-ligand as being the active component within or on the surface of 
the follicular EVs as these ligands are not typically expressed by mural granulosa cells 
until after the LH (Park, Su et al. 2004, Sekiguchi, Mizutani et al. 2004). 
Our recent studies on the content of follicular EVs have identified changes in the 
EV cargo from bovine follicles of different sizes (Navakanitworakul, Hung et al. 2016).  
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EVs from small antral follicles contained higher copy numbers of miRNA than did those 
EVs from large follicles and the miRNA present were also different.  In spite of this 
general trend for decreasing quantities of miRNA, the levels of five specific miRNA 
significantly increased:  miR-92b, miR-150, miR-328a-3p, miR-450a-5p, and miR-
2419-5p.  Two additional miRNA declined as follicle size increased:  miR19a-3p and 
miR-335 (Navakanitworakul, Hung et al. 2016).  The function of these changes is 
unknown.  These differences between small (younger) and large (advanced) antral 
follicles might imply either an active and selective mechanism exists for the loading of 
cargo into follicular EVs, or that simply the content of the EVs changes as a reflection of 
cellular changes in miRNA expression.  Studies are ongoing in our laboratories to 
identify the mechanisms of loading of miRNA into follicular EVs and to determine if this 
process is passive or controlled as our earlier study indicates.   
Follicular EVs have been characterized by multiple groups (Revelli, Delle Piane 
et al. 2009, da Silveira, Veeramachaneni et al. 2012, Sang, Yao et al. 2013, Sohel, 
Hoelker et al. 2013), yet we still do not yet know which cells produce the EVs found in 
follicular fluid.  We theorize that EVs are likely released by the neighboring granulosa 
cells (mural and cumulus) with lesser contributions from the oocyte and the theca cells 
because it is the granulosa cells that contact the follicular fluid directly.  However, until 
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properly tested this remains unknown.  It is generally considered that EVs would be too 
large to have entered from the theca vasculature, based on observations that large serum 
proteins >100 kDa are rate limited do enter the follicular fluid freely (reviewed in 
(Rodgers and Irving-Rodgers 2010)).  A protein of 100 kDa is generally considered to 
be less than 10 nm in diameter whereas our nanoparticle tracking analysis and electron 
microscopy (Fig. 2) found that follicular EVs range from the 30 nm to 350 nm in 
diameter.  Thus, EVs would be considered to be much larger than the largest serum 
proteins and as a result may be limited in their ability to pass through the basement 
membrane separating the theca and granulosa.  Of note however, the lipid bilayer of 
EVs could also dramatically impact their transport.  The passage of EVs through a 
cellular barrier by cell uptake, intracellular transport and subsequent export cannot be 
ruled out and ongoing studies are underway to determine the original source and transport 
mechanisms of follicular EVs (da Silveira, Veeramachaneni et al. 2012).  In addition to 
our lack of knowledge regarding the cells that release follicular EVs, our current work as 
well as previous published studies that describe follicular exosomes and microvesicles 
(Revelli, Delle Piane et al. 2009, da Silveira, Veeramachaneni et al. 2012, Sang, Yao et al. 
2013, Sohel, Hoelker et al. 2013), do not directly address the mechanism of follicular EV 
biogenesis or release.  Without this knowledge, it is impossible to differentiate between 
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large exosomes and small microvesicles. Therefore, we have chosen to call the bi-lipid 
vesicles we observe in follicular fluid as extracellular vesicles (EVs), indicating that the 
material is probably a mixture of exosomes and/or microvesicles, and not a population of 
one type or the other.  In addition to an overlap in size, it is now known that many of the 
so called “exosome specific” markers can also be associated with some microvesicles.  
This may not be a trivial concern, as major differences in the cargo and membrane 
components derived from these two different pathways may exist.   
EVs isolated from follicles of different sizes differ in their ability to affect gene 
expression in the cumulus cells.  We found increased expression of genes with known 
functions in cumulus expansion were activated by EVs from small but not large follicles 
(Fig. III-5).  This result is counter intuitive since it might be assumed that the COC 
within the large follicles that normally reacts to the LH surge to induce cumulus 
expansion.  One possible explanation is that small follicles contain EVs that support 
cumulus expansion and that these EVs are bound / taken up by COC during follicular 
development and the remaining (or newly produced) EVs in large follicles lack the ability 
to promote cumulus expansion.  Another possibility is that follicular fluid from large 
follicles contains inhibitory factors that are not active in small antral follicles.  Hosoda 
and Terada (2007) (Hosoda and Terada 2007) used filtration fractionation of follicle fluid 
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from large bovine follicles and determined that a >100 kDa fraction was associated with 
an inhibitory factor that blocked the cumulus expanding activity of EGF (Hosoda and 
Terada 2007).  Since our isolation techniques used centrifugation primarily rather than 
filtration, the type of vesicles from our studies and the isolates from the Hosoda and 
Terada (Hosoda and Terada 2007) might overlap in size.  It is therefore possible that an 
inhibitory factor associated with our EVs isolated from large follicles might limit their 
biologic activity.  Future studies will be aimed at determining the differences in 
follicular EV cargos as follicles mature.     
In conclusion, our studies have found a physiological effect of follicular EVs.  
These EVs were able to stimulate cumulus expansion and to up-regulate cumulus gene 
expression in vitro.  Our current and futures studies are directed towards further defining 
the miRNA and protein cargos associated with follicular EVs and mechanisms of uptake, 











X. Chapter IV: Follicular Extracellular Vesicles Differentially Regulate 
Bovine Granulosa Cell Proliferation in a Stage-Specific and 




The most important role of the female gonad, the ovary, is to produce fertilizable and 
healthy eggs.  In the ovary, the oocyte is enclosed within the ovarian follicle, which is 
one of the most dynamic tissues in the body, with tremendous proliferation, 
differentiation, and apoptosis happening within days.  At the later stages of 
folliculogenesis (the process of follicle growth), the antral follicle is defined by means of 
the formation of an antrum in a follicle, which is filled with a serum-like fluid called 
follicular fluid (FF) (Hennet and Combelles 2012).  Follicular fluid is a rich, complex 
fluid containing nucleic acids, proteins, steroids, and hormones, and is thought to isolate 
the oocyte and its associated cumulus cells from the endocrine mural granulosa cells.  
This isolation however, has given rise to complicated and intricate cellular networks that 
facilitate the exchange of cellular messages between the cumulus-enclosed oocyte and the 
segregated mural granulosa cells (Rodgers and Irving-Rodgers 2010).  Recently, 
extracellular vesicles (EVs) have also been found in the FF, and they have been 
hypothesized to act as yet another cellular mechanism to facilitate cross talk across the 
follicular antrum (da Silveira, Veeramachaneni et al. 2012, Sang, Yao et al. 2013, Sohel, 
Hoelker et al. 2013, Diez-Fraile, Lammens et al. 2014, Santonocito, Vento et al. 2014).  
 Release of EVs appears to be a phenomenon exhibited by all cells with two major 
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known mechanisms of EV biogenesis (Cocucci and Meldolesi 2015).  This includes 
exosome biogenesis, where inward budding of the multivesicular body (MVB) membrane 
generates intraluminal vesicles (i.e., exosomes of 30-200 nm diameter) that are released 
into the extracellular space upon fusion of MVB with the plasma membrane (Kowal, 
Tkach et al. 2014).  Microvesicles are produced by plasma membrane blebbing and 
results in a broad range (30-1000 nm) of vesicles sizes (Alenquer and Amorim 2015).  
Due to the overlap of markers and sizes of exosomes and microvesicles, “extracellular 
vesicle” (EV) has been adopted as an inclusive term that encompasses both kinds of 
vesicles outside the plasma membrane (Cheung, Keerthikumar et al. 2016).   
Exosomes and microvesicles both have been implicated in transmission of signaling 
molecules including nucleic acids, lipids and proteins to influence cellular behaviors 
(Tkach and Thery 2016).  The first observation of functional EVs outside of cells was 
made in 1967 by Dr. H. Clarke Anderson in his pioneering studies of bone calcification 
(Anderson 1967).  Recently, EVs have been implicated in a variety of physiologic and 
pathologic processes within various tissues.  In the cardiovascular system, EVs has been 
shown to have a cardioprotective role in which they are enriched in cardioprotective 
miRNA (Barile, Moccetti et al. 2016).  Extracellular vesicles also have known to be able 
to serve as the communication mediators between myelinating glia and neurons, which is 
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important for neuronal survival and synapse plasticity (Budnik, Ruiz-Canada et al. 2016).  
In pathological conditions, EVs have been described participating in the pathogenesis of 
neurodegenerative diseases and have been applied as potential biomarkers (Thompson, 
Gray et al. 2016).  Moreover, tumor cells are known to secrete substantial amounts of 
EVs, and the tumor secreted EVs appear to be critical for tumor survival, proliferation, 
and metastasis (Tkach and Thery 2016).    
Extracellular vesicles isolated from follicular fluid are known to differentially carry 
miRNA dependent upon the origin of the samples be it from different stages of the 
follicular maturation, different ages of the donor females, and under different disease 
conditions such as polycystic ovarian syndrome (da Silveira, Veeramachaneni et al. 2012, 
Sang, Yao et al. 2013, Sohel, Hoelker et al. 2013, Diez-Fraile, Lammens et al. 2014, 
Roth, McCallie et al. 2014, Santonocito, Vento et al. 2014, da Silveira, Winger et al. 
2015, Moreno, Nunez et al. 2015).  In addition, ovarian granulosa cells have been 
shown to take up fluorescently labeled vesicles (da Silveira, Veeramachaneni et al. 2012, 
Sang, Yao et al. 2013, Sohel, Hoelker et al. 2013, Diez-Fraile, Lammens et al. 2014, 
Roth, McCallie et al. 2014, Santonocito, Vento et al. 2014, da Silveira, Winger et al. 
2015, Moreno, Nunez et al. 2015).  Recently, follicular fluid EV treatment of cumulus-
oocyte-complexes was shown to induce cumulus expansion and initiate the corresponding 
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cumulus gene expression changes associated with expansion (Hung, Christenson et al. 
2015).  Additionally, treatment of granulosa cells with follicular EVs from both mid-
estrus and pre-ovulatory follicles which had abundant levels of miR-27b, miR-372, and 
miR-382 was shown to decrease expression of inhibitor of DNA binding/differentiation 2 
(ID2), a target of these abundant miRNA (da Silveira, Carnevale et al. 2014).  Both of 
these studies while indicating a functional effect of EVs are compromised by the purity of 
EV preparations, as EV isolation even under “gold-standard” ultracentrifugation 
protocols are still far from 100% pure.  This has raised concerns of whether material that 
co-precipitates may also be contributing to the functional effects attributed to EVs.  In 
our original study, we observed different functional effects of the follicular EVs based on 
the size of the follicle from which the fluid was isolated (Hung, Christenson et al. 2015).  
In this current study, we investigate whether stage-specific follicular EVs have 
differential effects on granulosa cell proliferation, a cellular function critical for rapidly 
growing follicles as they develop into ovulatory follicles.  In this study we applied a 
combination of EV isolation methodologies to yield highly purified EVs and then 
examined their effects on cell signaling pathways involved in cellular proliferation and 




EV characterization and uptake of EVs by granulosa cells 
Follicular fluid EVs were characterized using a battery of different molecular and 
visual methods.  Western blot analysis for the exosomal marker, CD81, indicated that 
the amount of CD81 decreased as follicle size increased [equivalent protein loaded (10 
g)/lane; Figure IV-1A].  Nanoparticle tracking analysis indicated a single peak of 100-
150 nm diameter particles across the different sized follicles (Figure IV-1B), and 
follicular fluid from 3-5mm follicles (hereafter called small follicles) was more 
concentrated in particles than those from 6-9mm and >9mm follicles (hereafter called 
medium and large follicles, respectively).  Electron microscopy of EVs negatively 
stained on grids indicated the presence of a typical cup shape morphology in all the 
samples indicating the existence of EVs, smaller material (10-20 nm) was prominently 
observed in the background (Figure IV-1C).  
In order to confirm that the granulosa cell can take up EVs, granulosa cells were 
exposed to PKH67-fluorescently labeled EVs.  Green puncta were observed in the 
cytosol of granulosa cells indicating that EVs were taken up by granulosa cells (Figure 
IV-2B).  Furthermore, flow-cytometry of granulosa cells exposed to the fluorescently 
labeled EVs also indicated uptake (Figure IV-2B).  The potential effect of residual dye 
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Figure IV- 1 Characterization of follicular fluid EVs.   
Extracellular vesicles from small (3-5mm), medium (6-9mm), and large (>9mm) antral 
follicles were subjected to A) Western blot analysis for the EV marker, CD81, using equal 
volumes of protein as demonstrated by a total protein staining, B) nanoparticle tracking 
analysis (NTA) shows the mean size distribution and numbers of particles for 3 
independent samples at the three follicle sizes and C) transmission electron microscopy 






Figure IV- 2 Uptake of fluorescently labeled EVs by bovine granulosa cells.   
Bovine granulosa cells from 3-5 mm follicles were exposed to PKH67-labeled EVs 
isolated from small bovine antral follicles and then subjected to confocal imaging (upper) 
and flow cytometry (lower).  A) Granulosa cells exposed to negative control showed no 
staining and complete lack of fluorescence by flow cytometry. B) Treatment of granulosa 
cells with labeled EVs showed punctate staining after 24 h of incubation and FITC 






Follicular-stage specific EVs modulate granulosa cell proliferation  
Treatment of granulosa cells for 24 h with EVs (100 μg protein/ml) from small antral 
follicles induced a 3.4-fold increase in BrdU incorporation compared to the non-treated 
controls while EVs from medium and large follicles only increased BrdU incorporation 
2.3- and 1.6-fold, respectively (Figure IV-3A).  The effect of small follicle EVs on BrdU 
incorporation were further strengthen by showing that the effect of EVs was 
concentration-dependent (5, 20, 100 μg/ml; Figure IV-3B).  Treatment with EVs from 
small follicles increased granulosa cell number by 2.03 and 2.11 fold as determined by 
hematocytmetry counting in two independent experiments (n=2).  In order to eliminate 
other confounding aspects that might influence the cell proliferation assay, we examined 
cell attachment and cell apoptosis following exposure to EVs.  After 30 min of 
simultaneously seeding of granulosa cells and EVs, the number of granulosa cells, which 
attached on the plate were not different across treatment groups but were higher than 
control (Figure IV-3C).  Additionally, we observed no differences in granulosa cell 
apoptosis after treatment with EVs for 24 h as determined by propidium iodide staining 
followed by flow cytometry (Figure IV-3D). 
Because the cell proliferative activity was greatest in small follicles and these 
collections contain a mix of atretic and non-atretic follicular fluid, we further refined the 
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experiment by collecting follicular fluid from large numbers (~100 follicles/each 
replicate) of individual small antral follicles.  These follicles were then individually 
determined to be either non-atretic or atretic based on granulosa cell expression of tissue 
inhibitor of metallopeptidase 1 (TIMP1) for each follicle.  Three independent collections 
were done to generate three pools of follicular fluid from atretric and 3 pools from non-
atretic FF and the EVs isolated from these pools were characterized for CD81 and ability 
to influence cell proliferation.  Follicular EVs from non-atretic and atretic follicles 
carried similar levels of exosome marker CD81 and showed equivalent activities on GC 
proliferation (Figure IV-4). 
To further eliminate the possibility that residual molecules co-precipitating with EVs 
might be influencing cell proliferation, which can be seen in Figure 1C, EVs were further 
purified through size exclusion columns.  This purification step removed most of the 
residual molecules in the background yielding a highly purified preparation of follicular 
EVs (Figure IV-5A).  This additional column purification step retained the activity on 
inducing granulosa cell proliferation (Figure IV-5B), and further indicates that the EVs 





Figure IV- 3 Effects of follicular fluid EVs on granulosa cell proliferation, 
attachment, and apoptosis.   
Granulosa cells were exposed to follicular fluid EVs from small (3-5mm), medium (6-
9mm), and large (>9mm) follicles and evaluated for effects on: A, B) cell proliferation, 
C) cell attachment, and D) apoptosis.  A) Depicts changes following 24 h exposure to 
EVs (100 μg/ml) from the different sized follicles, B) Depicts a concentration-dependent 
effect of EVs from small antral follicles on cell proliferation.  C) Depicts effect of EVs 
from different sized follicles on cell attachment, while D) depicts effect of EVs from 
different sized follicles on apoptosis. a,b,c,dMeans  SEM (n=3) with different superscripts 






Figure IV- 4 Comparison of EVs from non-atretic and atretic follicles.   
A) Follicles were categorized by expression of TIMP1 (delta Ct method) as non-atretic or 
atretic.  For each replication (n), a three Ct difference was used to define the groups, FF 
from all follicles that exhibited an intermediate delta Ct were discarded.  B) The fold 
change in BrdU incorporation for the pooled follicular EVs from non-atretic (n=3) or 
atretic (n=3) follicles are shown.  a,bMeans  SEM with different superscripts were 






Figure IV- 5 Comparison of the purity and activity of EV preparations following 
isolation by ultracentrifugation or ultracentrifugation plus size exclusion 
chromatography.   
Extracellular vesicles isolated by both protocols were A) imaged under TEM, and B) 
activities on cell proliferation were tested.  a,b Means  SEM (n=3) with different 






Small follicle EVs affect granulosa cell protein kinase cell signaling factors  
To examine the cell signaling pathways that mediate EV action within the granulosa 
cells, we used a Kinexus antibody-based array that examines 877 cell signaling proteins.  
Bovine granulosa cells from small follicles were treated with or without EVs (100 g 
protein/ml) for 24 hour as above and then cell lysates were collected and subjected to the 
antibody array.  A total of 106 cell signaling proteins changed more than 25% after EV 
treatment in granulosa cells, with 66 increasing and 40 decreasing in total protein levels.  
Post-translational modifications of proteins (i.e., phosphorylation) also changed in 
granulosa cells exposed to EV, again looking at only those that changed 25% or more 
after EV treatment, we observed that 67 exhibited increased and 19 that had decreased 
phosphorylation (Table 1).  Two of the top upregulated genes, Akt and Mcl-1 were 




Table IV- 1 Proteins showed 25% increase or decrease upon EVs treatment in the kinase 
array 
 
Covered box: phosphorylated antibodies 
*target of abundant miRNA in large antral follicle  
Name fold change Name fold change Name fold change Name fold change
Src* 39.72 PP4C (X/C)* 1.46 p38g MAPK* 1.31 ASK1 0.71
Mcl1* 3.53 B-Raf 1.45 Histone H2A.X 1.30 Cdc25C 0.70
p53* 3.02 PKR1* 1.44 PKCe* 1.30 Rb 0.70
RSK1* 2.67 MEK2* 1.43 SMG1* 1.30 DUSP6 0.69
Akt1 (PKBa)* 2.59 Hsp90b 1.43 ERK5 1.30 Kit 0.69
GSK3a* 2.22 Csk* 1.43 ZIPK* 1.30 Cyclin D1 0.68
PKA R2a (PKR2)* 2.16 COX2* 1.43 Hsp70* 1.29 PDK1 0.68
MEK2* 2.10 Ezrin* 1.42 Bcr* 1.29 CD63 0.68
ERK3* 2.06 ALK* 1.42 Kit* 1.29 Krs-1 0.68
PKCh* 2.01 ERK1 1.42 Hpk1* 1.29 Myc 0.68
Ephrin-B2* 1.88 p21 CDKI1* 1.42 BRD2* 1.29 CDK6 0.68
Hsp27* 1.86 CDK2* 1.41 mTOR* 1.29 CDK4 0.67
Tau* 1.86 KDEL Receptor (KR10)* 1.41 I1PP2A (PHAPI)* 1.29 ErbB2 0.66
PI3-Kinase* 1.84 B23 (NPM)* 1.41 PAK1* 1.28 CDK9 0.66
NIK* 1.82 Cdc2 p34 1.41 hHR23B* 1.28 AMPKa2 0.66
BCL* 1.80 p53* 1.41 CaMK2a* 1.28 Synapsin 1 0.65
MEK3b 1.80 Rac1/cdc42* 1.40 MAPKAPK2* 1.28 Paxillin 0.65
Trail* 1.79 FAK* 1.40 MEK5 1.27 FAS 0.64
MEK1* 1.75 MEK1* 1.40 MEK2* 1.27 PAKa 0.64
eIF2a* 1.75 VIM* 1.39 PYKSD8 1.27 IRS1 0.64
CaMK1d* 1.74 VEGF-C* 1.38 MyoD* 1.27 WNK1 0.64
Chk1* 1.74 RIP2/RICK* 1.38 PTP1D/SHP2* 1.27 Fos 0.63
MEK3/6 1.70 ERK5* 1.38 MST3* 1.26 MEK1 + B23(NPM) 0.63
GNB2L1 1.69 Rac1 1.37 ErbB4* 1.26 STAT3 0.62
Nek2* 1.69 Akt1 (PKBa)* 1.37 PLCg1* 1.26 Bcl-xS/L 0.61
EGFR* 1.67 eIF4E* 1.37 Tau* 1.26 PTEN 0.60
c-Cbl* 1.66 B23 (NPM)* 1.37 PKCg* 1.26 STAT4 0.60
Caveolin 1* 1.64 PYK* 1.37 LIMK1/2* 1.26 NMDAR2B 0.59
Nek2* 1.62 Catenin a* 1.36 PKCd* 1.25 Src 0.57
PKCg* 1.61 ILK1* 1.36 ERK1 1.25 PKG1b-NT 0.56
ZAP70* 1.60 HDAC4/5/9* 1.36 JAK2* 1.25 PKCt 0.53
Fes* 1.59 MEK3* 1.35 Smad2* 1.25 JAK1 0.53
Hsp47* 1.58 PKCl* 1.35 Elk1* 1.25 HDAC4 0.51
FAK* 1.58 MLC* 1.35 MEKK2 0.75 Abl 0.50
MST3* 1.58 NFKB p65* 1.35 CD45 0.75 CDK2 0.50
Csk* 1.56 MST1* 1.34 STAT2 0.75 IRAK1 0.45
Hsp27* 1.54 Jun* 1.34 Chk1 0.75 Integrin a4 0.43
PKCt* 1.53 LAR* 1.34 PKA Ca/b 0.74 Hsc70 0.42
PKCm (PKD)* 1.52 Lck* 1.34 CDK5 0.74 VEGFR2 0.39
Crystallin aB 1.52 ERK1* 1.33 RONa 0.74 STAT1 0.35
NME7* 1.52 CAMK2d* 1.32 Progesterone Receptor 0.74 STAT6 0.21
NFkappaB p65* 1.52 DNAPK 1.32 Rb 0.73 PKCl 0.05
CDK1* 1.51 SIK3* 1.32 Lck 0.73
CPG16/CaMKinase VI* 1.51 Met* 1.32 JAK1 0.73
FRK* 1.49 Cofilin* 1.31 GRK2 0.73
TYK2 1.48 p70 S6K* 1.31 MEK3 0.73
ANKRD3* 1.48 PKD (PKCm)* 1.31 IkBa 0.73
CDK1/CDC2* 1.48 PP2A/Aa/b* 1.31 DUSP1 (MKP1) 0.72
Caspase 3* 1.47 Cortactin* 1.31 MEK4 0.72
HDAC5* 1.46 SOCS2* 1.31 Akt2 (PKBb) 0.71
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Figure IV- 6 Western blot validation of kinase array results.    
Western blot analysis for Mcl1 and Akt confirmed that these top Kinase array proteins 






Analysis of cellular signalling pathways  
In order to elucidate possible cell signalling pathways, we used a combined approach 
using kinase array data and miRNA expression data.  Breifly, we examined those 
proteins/translational modifcations which were up-regulated in response to EV treatment 
(from small follicles) and might be essential for EV-induced cell proliferation in small 
antral follicles.  These genes would be predicted to decline as small follicles become 
large follicles as cellular proliferation decreases during this transititon. Since, microRNA 
(miRNA) function primarily to suppress expression of their target transcripts, we 
evaluated whether abundant miRNA present in EVs from large follicles (compared to 
small follicles) from our previous study (GEO-GSE74879) (Navakanitworakul, Hung et 
al. 2016), could modulate the kinase array identified proteins.  We did this by comparing 
those predicted miRNA target genes to the list of kinase array identified genes which 
increased in cells treated with EVs.  This resulted in an overlap of 101 genes that were 
subsequently analysed by IPA.  These 101 genes were highly related to post-
translational modification, cell growth, proliferation, and survival and to the signalling 
pathways of HGF, Erbb, GnRH, and Src (Figure IV-7). 
 
Src and JNK signaling implicated in EV-mediated cell proliferation 
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In order to test the IPA analysis predictions and dissect out specific signaling 
pathways contributing to the EV-mediated cellular events, specific kinase inhibitors were 
applied into the cell culture system with/without the presence of EVs.  Treatment with 
the Src inhibitor (PP2; 0-50 µM) and with the JNK inhibitor (SP600125; 0-50 µM) 
completely blocked induction of cell proliferation (i.e., BrdU incorporation) by EV 
treatment while not affecting the proliferation of GC receiving no treatment (Figure IV-
8).  Granulosa cells treated with the PI3K inhibitor LY294002; 0-50 µM) or with the 
MEK1/2 inhibitor (U0126; 0-50 µM) had decreased levels of EV-mediated proliferation 
with a dose-dependent trend but also affected the proliferation in the no-EV control 
groups (Figure IV-8).  Treatment of GC with the p38 inhibitor (SB203580; 0-50 µM) 
did not influence the ability of EV to stimulate proliferation (Figure IV-8).  To exclude 
the off-target effects, granulosa cells were exposed to PP3 (a non-functional PP2 
analogue) in combination with EV treatment.  PP3 did not influence EV-mediated cell 
proliferation at any concentration tested (Figure IV-8). 
  
Src influenced EV-mediated cell proliferation was independent of regulation of uptake 
Src is known to regulate endocytosis which is one way for EVs to enter the cell 
(Donaldson, Porat-Shliom et al. 2009).  To test if inhibition of Src kinase activity 
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affected the uptake of EVs by granulosa cells, flow-cytometry was used to define the 
level of uptake of PKH67-fluorescently labeled EVs following treatment with the Src 
kinase inhibitor, PP2.  Treatment of PP2 did not influence uptake of EVs in granulosa 
cells as the numbers of green-positive cells were similar despite increasing the 






Figure IV- 7 Predicted downstream pathways involved in EV mediated cellular 
proliferation.   
Targets of miRNA which are abundant in the large follicles (GEO-GSE74879) were 
predicted by IPA in advance and then compared to the genes which were regulated with 
the treatment of EVs from small follicles.  The overlapping 101 genes were then 
subjected to IPA in order to predict the following regulator molecules and canonical 






Figure IV- 8 Identification of downstream signaling pathways affected by EV 
treatment.   
Specific inhibitors were used to elucidate downstream cell signaling pathways in 
granulosa cells following EV treatment.  Pathways evaluated included Src (PP2), JNK 
(SP600125), PI3K (LY294002), MEK1/2 (U0126), and p38 (SB203580).  A non-
functional analog of PP2, PP3, was used to rule out potential off-target effects for the Src 
inhibition study.  *Means  SEM (n=3) with different superscripts were statistically 






Figure IV- 9 Effect of Src inhibition by PP2 on EV uptake.   
Influence of PP2 on EV uptake was tested by flow cytometry.  A) Representative image 
of effect of PP2 on EV uptake under flow cytometry (PP2: 50 M), and B) effect of PP2 
on EV uptake in a dose-dependent design.  a,bMeans  SEM with different superscripts 






EVs from different size follicles were taken up by granulosa cells at different levels 
One explanation for the differential ability of EVs from small, medium and large follicles 
to promote cell proliferation is that they may be taken up by the cell differently.  To test 
this hypothesis, EVs from different size follicles were labeled with PKH67 before 
treatment of granulosa cells.  Extracellular vesicles from small antral follicles exhibited 
a preferential uptake by granulosa cells.  The intensity of green positive cells following 
treatment with EVs from small follicles was twice that observed following treatment of 
EVs from medium and large antral follicles at both 2 h and 24 h (Figure IV-10A).  To 
further evaluate cellular uptake, another preparation of EVs from small follicles, which 
had half the numbers of EVs as determined by protein concentration were tested (particle 
concentration of FF-EV is proportional to its protein concentration, Figure IV-11).  Even 
with half the number of small follicle EVs, granulosa cell uptake was still greater for the 
small versus medium and large follicles (Figure IV-10B).  Meanwhile, this phenomenon 
was consistent regardless of the source of granulosa cells [i.e., small, medium (Figure IV-
12A) and large (Figure IV-12B) antral follicles.  To demonstrate that EVs were in the 
cells and not just associated with the cells, we used the ImageStream imaging flow 
cytometer.  The amount of EVs loaded was based on protein concentration.  
Additionally, in order to prove that a similar number of EVs were used, particle 
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concentrations of EVs from small and large follicles were quantified by nanoparticle 
tracking analysis and Imagestream flow cytometry.  Both of these methods confirmed 
that similar concentrations of EVs from small and large follicles were used in these 
experiments (Figure IV-10E-G).  Granulosa cells took up EVs isolated from small 
follicles at twice the level as EVs isolated from large follicles (Figure IV-10C), which 
was consistent with standard flow cytometry results in Figure 8A.  The internalized EVs 
were observed in the cells as green puncta in the cytosol (Figure IV-10D).  
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Figure IV- 10 Extracellular vesicles from different sized antral follicles are 
differentially taken up by granulosa cells.   
Bovine granulosa cells from small antral follicles were cultured with labeled EVs from 
small, medium, or large antral follicles for 2 h or 24 h, and the level of uptake was 
measured by flow cytometry.  A) Level of EV uptake by FITC intensity under flow 
cytometry, and B) overlap image showed the levels of uptake of EV from different sized 
follicles, including a set where EVs from small follicles were given at one half the dose 
(Small 0.5).  Uptake was also examined by Imagestream (imaging flow cytometry) with 
labeled EVs from small and large follicles.  C) Level of EV uptake were presented by 
FITC intensity under imageflow cytometry, and D) corresponding images of granulosa 
cells treated with EVs from small and large follicles showed the internalized labeled EVs 
(green).  The equal number loading was determined by E) imaging flow cytometry and 
F) nanoparticle tracking analysis and G) the images of labeled EVs (green spots) acquired 






Figure IV- 11 Particle concentration of FF-EV is proportional to its protein 
concentration.   
Three independent collection of EVs were collected from FF.  Their particle and protein 






























Figure IV-12 Extracellular vesicles from different sized antral follicles are 
differentially taken up by granulosa cells of medium and large follicles.   
Bovine granulosa cells from A) medium and B) large antral follicles were cultured with 
labeled EVs from small, medium, or large antral follicles for 2h, and the level of uptake 








This study provides the first evidence that EVs isolated from ovarian FF can impact 
granulosa cell proliferation.  Additionally, we were able to show that the Src and JNK 
pathways were involved in this stage-specific cell proliferation response as EVs isolated 
from small follicles exhibited the greatest activity on proliferation.  We also proved that 
this differential activity of EVs was a result of the differential capacity of EVs themselves 
being taken up, which provides a potential model for studying the membrane proteins 
crucial for EV uptake.  Additionally, in this study we developed a combination approach 
using the “gold” standard ultracentrifugation method combined with a column size 
exclusion method to significantly reduce/eliminate residual precipitants within the EV 
preparation.   
Folliculogenesis is a well-orchestrated process regulated by endocrine, paracrine, and 
autocrine signaling (Roy 1994).  Gonadotropins, which include follicle stimulating 
hormone (FSH) and luteinizing hormone (LH), are certainly the most critical and well-
defined players serving as endocrine signaling hormones from the pituitary (Kumar 
2005).  However, there are also paracrine and autocrine factors such as insulin-like 
growth factor (IGF), epidermal growth factor superfamily (Erb family, EGF ligands), 
transforming growth factor beta (TGFβ) superfamily, fibroblast growth factor (FGF), 
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within the ovary, which have proven to be essential in stage specific manners (Monget 
and Bondy 2000, Knight and Glister 2006, Chaves, de Matos et al. 2012).  Extracellular 
vesicles isolated from FF of different conditions have been reported to carry different 
miRNA, indicating a role as stage-specific signaling mediators (da Silveira, 
Veeramachaneni et al. 2012, Sang, Yao et al. 2013, Sohel, Hoelker et al. 2013, Diez-
Fraile, Lammens et al. 2014, Roth, McCallie et al. 2014, Santonocito, Vento et al. 2014, 
da Silveira, Winger et al. 2015, Moreno, Nunez et al. 2015).  In this study, we showed 
follicular EVs from different size antral follicles exhibiting differential activity on 
granulosa cell proliferation in which EVs from small follicles were most active, and this 
differential activity was correlated to physiological condition where proliferation is 
highly activated in small antral follicles.  
Granulosa cell proliferation is controlled by a complex signaling network (Field, 
Dasgupta et al. 2014).  Application of antibody-based array provided a comprehensive 
evaluation of EVs effects on signaling within recipient granulosa cells.  Combined with 
our previous small RNA-seq on follicular EVs from different size follicles (GEO-
GSE74879), we were able to identify several pathways (Src, HGF, GnRH, and ErbB 
pathways) that follicular EVs from small follicles may use to regulate granulosa cell 
proliferation.  Further inhibitor studies enabled us to dissect these predicted pathways, 
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and to elucidate the JNK pathway as another critical pathway for EV-induced cell 
proliferation.  Src kinase has been shown as downstream of several signaling pathways 
in the granulosa cells, which include FSH, LH, growth differentiation factor 9 (GDF9)/ 
bone morphogenetic protein 15 (BMP15), protein kinase C (PKC), and progesterone 
(Rice, Chaudhery et al. 2001, Du, Huang et al. 2012, Mottershead, Ritter et al. 2012, 
Yamashita, Okamoto et al. 2014).  Similarly, the JNK pathway has been reported to 
affect granulosa cell proliferation by regulating the cell cycle, and also is associated with 
pathways such as FSH and GDF9/BMP15 (Sriraman, Modi et al. 2008, Miyoshi, Otsuka 
et al. 2010, Oktem, Buyuk et al. 2011, Mottershead, Ritter et al. 2012).  While the 
experiments used a fairly late time point (24 h) in relationship to FF exposure to examine 
cell signaling molecules via the Kinome array, we were able to identify several pathways.  
Most importantly blockade of these pathways with inhibitors simultaneous with exposure 
to FF-EV was able to confirm these pathways involvement.  Here, we showed that 
follicular EVs can affect granulosa cells through these cell signaling pathways.   
Isolation of follicular EVs began with a standard multi-step ultracentrifugation 
protocol (Thery, Amigorena et al. 2006).  Differential ultracentrifugation is regarded as 
the best protocol to collect EVs from various body fluids because of its ability to pull 
down materials simply based on their density (Szatanek, Baran et al. 2015).  With a 
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further step of sucrose gradient, we proved that the majority of vesicles collected by 
ultracentrifugation from FF were exosomes in our previous study (Navakanitworakul, 
Hung et al. 2016).  However, the purity of post-ultracentrifugation EVs is still debated, 
and concern arises mainly because of the residual background materials observed under 
EM.  To further eliminate and produce a highly purified EV preparation, we combined 
ultracentrifugation with a size exclusion column and successfully removed most of the 
small residual materials.  The subsequent BrdU assays showed that the additional step of 
removing contaminating non-vesicle material did not influence the result of BrdU assay, 
and thus strengthens the observation that EVs contributed most of the activity on 
inducing granulosa cell proliferation.  Our study provides an improved protocol for 
purifying EVs and provide strong evidence that EVs are the functional components. 
The effects of EVs on cellular functions can be regulated through several manners 
including EV secretion, EV cargo selection, as well as EV uptake.  Most studies on EV 
uptake focus on the ability of recipient cells to take up EVs (Mulcahy, Pink et al. 2014).  
Conventional and imaging flow cytometry were used to quantify the level of EV uptake 
after treatment of granulosa cells with fluorescently labeled EVs, and both of them 
yielded very similar results.  Three different approaches were used to ensure that the 
cells were given similar amount of labeled EVs including determining protein 
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concentration of EVs by the bicinchoninic acid (BCA) assay, determining particle 
concentration by nanoparticle tracking analysis and imaging flow cytometry.  
Extracellular vesicles were equally applied across treatment groups (small and large 
follicles) in the individual experiments based on these methods.  Interestingly, 
nanoparticle tracking analysis and imaging flow cytometry however yielded different 
absolute levels of EVs, this can be attributed to methodological differences.  Imaging 
flow cytometry relies on fluorescent labeling of EVs and subsequent detection, 
conversely, nanoparticle tracking analysis does not rely on fluorescence and individual 
particles are more likely to be counted.  Based on our knowledge, this is the first 
demonstration showing that a single tissue (follicle) is able to produce stage-specific 
EVs, which have differential capacities of being taken up by specific target cells.  This 
finding also enables follicular EVs as a potential model to identify surface proteins, 
which could be critical for EV uptake.  
The bovine model for the study reproduction is useful not only because of because of 
its importance to agriculture but also because it has many similarities to human 
reproduction; both species generate multiple follicular waves resulting in a single 
ovulation and the bovine reproductive cycle is nearly as long as the menstrual cycle of 
women.  The availability of tissue and size of the bovine ovary makes it an effective 
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model for studying the physiological role of follicular EVs and even the basic biology of 
EVs.  When collecting EVs from the FF, one concern is the existence of atretic follicles.  
In our previous study, we proved that the majority of FF originating from 3-5 mm and >9 
mm follicles was from non-atretic follicles (Navakanitworakul, Hung et al. 2016).  In 
this study, we compared follicular EVs from non-atretic and atretic small follicles, which 
were separated based on expression of TIMP1, a marker previously shown to be 
increased in atretic follicles (Hatzirodos, Hummitzsch et al. 2014).  Surprisingly, 
follicular EVs from non-atretic and atretic small follicles exerted similar effects on the 
proliferation of granulosa cells.  This suggests that EVs isolated from small follicles 
inherently stimulate cell proliferation, regardless of the physiologic state the follicle is in.  
This might suggest that the EVs isolated are highly similar and that the differences 
between these two types of follicles resides in the cell’s ability to respond to the EVs.  
Further studies will be necessary to establish what differences/similarities exist in the 
atretic and non-atretic follicle EVs and/or whether cell responsiveness to EVs in these 
two types of follicles differ.   
 
In conclusion, this study provides evidence that follicular EVs from different sized 
follicles exhibit different functional outcomes on granulosa cells.  Extracellular vesicles 
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from highly proliferative small follicles were shown to induce granulosa cell proliferation 
while those from large antral follicles were only able to moderately stimulate 
proliferation.  We also proved the activity is mainly from EVs and not residual materials 
that simultaneously co-precipitate with the EVs, therefore these studies support the use of 
the ultracentrifugation EV collection methodology.  The ability of EVs to induce cell 
proliferation was clearly prevented by inhibitors of the Src and JNK signaling pathways, 
while less compelling evidence for PI3K and ERK pathways were obtained.  We also 
observed a differentially capacity of EVs being taken up by granulosa cells, which might 
explain the differential effects of EVs on cell proliferation.  Interestingly, this difference 
in EV uptake was dependent upon the source of follicular EVs (i.e., small or large 
follicles), and was not dependent upon the size of the follicle from which the cells were 
isolated.  These studies support a role for EVs in cellular function within the developing 
antral follicle. 
 
Material and Method 
Follicular fluid collection 
Bovine ovaries were collected from a local abattoir and because the animals were not 
used specifically for research purposes our Institutional Animal Care and Use Committee 
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ruled that the collection of ovaries from the abattoir does not constitute animal research 
and is exempt from further review.  Ovaries (~150 ovaries / collection) were placed 
immediately into PBS and then transported 2.5 h to the University of Kansas Medical 
Center at 20-24 C temperature in preparation for ovarian FF aspiration.  Follicular 
diameters were determined by individually measuring follicle diameters; follicles were 
designated into three different groups based on diameter (3-5 mm - small, 6-9 mm – 
medium and > 9 mm – large).  Follicular fluid was aspirated using a tuberculin syringe 
(28 gauge needle) for small follicles and a 5 ml syringe with a 20-gauge needle for 
medium and large follicles.  Follicular fluid from individual follicles was then stored 
independently or pooled into 15ml aliquots based on experimental designs.   
Isolation of extracellular vesicles 
Extracellular vesicles were isolated using a differential ultracentrifugation method 
developed for serum isolation of exosomes(Thery, Amigorena et al. 2006) and recently 
validated for follicular fluid (Navakanitworakul, Hung et al. 2016).  Follicular fluid was 
diluted 1:1 with PBS and then spun at 800g for 5 min to pellet all cells including oocytes 
(the cell pellets were snap frozen at -80C or placed in Trizol).  Follicular fluid was then 
centrifuged at 2000g for 20 min followed by 12000g for 45 min to remove cellular debris 
and other large particles (large microvesicles and apoptotic blebs).  Samples were then 
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filtered through a 0.22 μm pore filter (Millipore) to further remove vesicles greater than 
220 nm.  Ultracentrifugation of the 1:1 mix follicular fluid:PBS was performed at 
110000g for 3 hours. Above centrifuge steps were perform in an OptimaTM L-100XP 
ultracentrifuge, using a swinging bucket SW32Ti rotor for large scale collection (15ml 
FF).  The resulting EV pellets were then resuspended in 4 ml PBS and spun again for 
1.5 hours at 110000 g in a TLA 100.4 fixed angle rotor.  A final wash with 1 ml of PBS 
was then performed and spun at 110000 g for 1.5 hours using a TLA 55 fixed angle rotor.  
All centrifugations were performed at 4°C.  The obtained pellets were re-suspended in 
PBS for further analysis.  When FF volumes were below 2ml the TLA110.4 rotor was 
used in place of SW32Ti until the last ultracentrifugation with TLA55 rotor.  
Nanoparticle tracking analysis 
To determine particle size and concentration, nanoparticle-tracking analysis (NTA) was 
performed with a Nanosight LM10 instrument (Nanosight, Salisbury, UK) outfitted with 
a LM14C laser. Each EV preparation was sampled three times to generate 3 independent 
dilutions.  These dilutions range from ~1:1000 to 1:10,000 for each sample (the dilution 
is determined empirically for each sample) and then each of the three dilutions is 
analyzed 3 times.  The overall average of these three dilutions was used as the 
experimental result for each sample.  From validation studies using dilution series, we 
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determined that NTA is most accurate between particle concentrations in the range of 2 × 
108 /ml to 2 × 109 /ml.  Thus samples were diluted to this level and absolute 
concentrations were then back calculated according to the dilution factor. 
Transmission electron microscopy 
EVs (10 mg/ml) were fixed overnight (2% glutaraldehyde and 0.1 M cacodylate buffer) 
and washed with 0.1 M sodium cacodylate buffer.  A glow discharge treated carbon film 
300 mesh grid was inverted and floated upside down on the drop containing fixed EVs 
(20 min).  Each grid was rinsed 7x with filtered distilled water then stained with 1% 
uranyl acetate.  All samples are examined in a JEOL-JEM-1400 transmission electron 
microscope at an 80-100 kV with 15,000x magnification.   
Western blot Analysis 
EV samples (10 μg protein) were lysed in SDS sample buffer with 50 mM DTT, heated 
for 5 min at 95 °C and subjected to electrophoresis using 12% SDS-PAGE in running 
buffer at constant 120 V for 1.5 hours.  Proteins were then electrotransferred onto 
polyvinylidenedifluoride membranes, and the membranes were blocked with 5 % (w/v) 
skim milk powder in Tris-buffered saline with 0.05 % (v/v) Tween-20 (TTBS) for 1 hour 
at RT.  Membranes were then probed with primary anti-CD81 (sc-166029), anti-Mcl1 
(sc-819), anti-Akt (sc-8312) and anti-Actin (sc-1616) antibodies for overnight at 4 °C in 
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TTBS (50 mM Tris, 150 mM NaCl, 0.05 % Tween20) followed by incubation with the 
secondary anti-mouse IgG or anti-sheep goat antibodies for 1 h. All primary antibodies 
were purchased from Santa Cruz Biotechnology Inc. Membranes were washed three 
times in TTBS for 10 min after each incubation step and detected by enhanced 
chemiluminescence (ECL) (GE Healthcare Bio-science, PA) per manufacturer’s 
instructions. To ensure that similar levels of total proteins were loaded on to westerns, we 
stained the membranes with Swift Membrane Stain (G Biosciences, St Louis MO) per 
manual instructions.  
Granulosa cell culture 
Primary granulosa cells isolated from small, medium and large follicles were cultured in 
DMEM/F12 supplemented with 1000 IU/ml penicillin, 1000 µg/ml streptomycin, 2 µg/ml 
recombinant human insulin, 1.1 µg/ml human transferrin, 1 ng/ml sodium selenite, and 
10% fetal bovine serum.  Fetal bovine serum was diluted with equal volume of 
DMEM/F12 and spun for 3 hours at 110000g to remove vesicles in advance.  Cells were 
cultured at 38.5℃ supplemented with 6% CO2.  Plating densities and specifics to assay 
are described.   
EVs labeling and imaging 
EVs were stained using the PKH67 Green Fluorescent Cell Linker Kit (Sigma Chemical 
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Corp, St Louis, MO) per manual protocol and pelleted by ultracentrifugation following 
several washes in PBS before final resuspension in PBS. To test if there is any residual or 
precipitant dye with this protocol, a negative control was performed in parallel under 
same protocol but without EVs.  For the negative control the same volume of PBS was 
added to the centrifuged tube.  Granulosa cells from small follicles were cultured as 
previously described and treated with an equal volume of labeled EVs or negative control 
solution in a chamber slide.  Extracellular vesicle uptake was then observed under a 
Zeiss Pascal 510 confocal microscope. 
Flow cytometry 
Bovine granulosa cells from small follicles were plated in 24-well dish at 105 cells/well 
with/without the treatment of labeled EVs and PP2, Src kinase inhibitor.  After 
treatment, granulosa cells were washed with PBS once before detaching by 
trypsinization.  Trypsin was neutralized by adding complete medium and cells were 
collected by centrifugation.  For apoptosis assay, granulosa cells were treated with 100 
µg/ml EV from small follicle and then stained with propidium iodide staining in advance 
to analysis.  The fluorescence level of cells was used to determine the level of EVs 
uptake under a BD LSR II (BD Biosciences), and data were analyzed with BD 
FACSDiva software (BD Biosciences).  For imaging flow cytometry, samples were run 
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on a Amnis ImageStream®X Mark II Imaging Flow Cytometer and analyzed with 
IDEAS® Software (EMD Millipore, Darmstadt, Germany).  In each of the cell and EV 
samples, 10000 and 100000 objects were collected, respectively.  
BrdU incorporation assay and cell attachment assay 
Bovine granulosa cells from small follicles were cultured in 96 well culture dishes at 5 x 
103 cells/well with or without EVs (see individual figure for concentration) collected 
from specific size follicles as indicated.  Cell proliferation was measured 24 hours later 
as BrdU incorporation according to the manufacturer’s protocol (Roche).  For inhibitor 
study, granulosa cells were cultured as described with addition of indicated kinase 
inhibitors, including PP2 (Millipore) for Src kinase, Ly294002 (Sigma-Aldrich) for PI3K 
kinase, SB203580 (LC laboratories) for p38 kinase, U0126 (Promega) for MEK1/2, and 
SP600125 (Sigma-Aldrich) for JNK kinase.  PP3 (Millipore) a PP2 analog was also 
used in specific experiments.  The concentration of each was described in individual 
figure legends.   
For analyzing effect of EV on cell attachment, bovine granulosa cells from small follicles 
were cultured with EVs from small, medium, or large follicles with controls with/without 
FBS.  Cells were seeded at the density of 4 x 105 cells/ml simultaneously with indicated 
supplements into 96 well plates.  Cells were then rinsed with PBS for three times and 
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fixed with 4% paraformaldehyde for 15mins.  After washing with PBS, the fixed cells 
were stained with crystal violet (5 mg/ml in 2% ethanol) for 10 mins.  Following with 
washing with water to remove the residual dye, the plate was air dried and then 2% SDS 
was used to dissolve crystal violet.  The plate was read at absorbance 550 nm on a 
FlexStation 3 Multi-Mode Microplate Reader (Molecular Devices). 
.  
KAM-880 antibody microarray 
Twenty-four hours after treatment, GC with EV treatment (100 µg/ml EVs from small 
follicle) and non-treatment control were washed twice with cold PBS before adding 
200μl of lysis buffer (20 mM MOPS pH7.0, 2 mM EGTA, 5 mM EDTA, 30 mM sodium 
fluoride, 60 mM β-glycerophosphate, 20 mM sodium pyrophosphate, 1 mM sodium 
orthovanadate, 1% Triton X-100, 1 mM phenylmethylsulfonylfluoride, 3 mM 
benzamidine, 5 μM pepstatin A, 10 μM leupeptin, 1 mM dithiothreitol).  Lysates were 
sonicated (Model Q800R, Active Motif, CA) with the following protocol: amplification 
75%, pulse on 15 s, pulse off 45 s, temperature 3°C.  Samples were then spun twice at 
16000 g for 30 mins each at 4°C before submitting on dry ice to Kinexus Bioinformatics 
Corp. (Vancouver BC, Canada).  The KAM-880 antibody microarray includes 518 pan-
specific and 359 phospho-site specific antibodies.  The background of this specific array 
187 
 
was described by McGinnis et al. (McGinnis, Pelech et al. 2014). 
Ingenuity pathway analysis (IPA) 
MicroRNA which are abundant in the large follicles (i.e., might be predicted to be 
inhibitory to cell proliferation) were identified from our small RNA-seq (GEO-
GSE74879) study. Their respective target genes were predicted through the use of 
Ingenuity® Pathway Analysis (IPA®, QIAGEN Redwood City, 
www.qiagen.com/ingenuity) and these predicted target genes were then compared to the 
differentially expressed proteins/translation modifications (kinase array results) following 
EV treatment.  The overlapping miRNA target genes and the kinase array identified 
proteins were then subjected to IPA analysis in order to identify possible cell signaling 
pathways.    
RNA preparation 
Total RNA was isolated from granulosa cells (GC) of individual follicle with Trizol 
(Invitrogen) according to the manufacturer’s protocol.  Briefly, GC were disrupted in 1 
ml of Trizol reagent and incubated for 15 min at room temperature following addition of 
200 μl of chloroform.  Subsequently, the aqueous solution was mixed with 500 μl of 
isopropanol.  In facilitate precipitation and visualization of RNA pellet, 1 μl glycogen 
(20 μg/μl) was added together with the RNA-isopropanol mixture solution and incubated 
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at RT for 10 min and spun at 12000 g for 15 min at 4 °C. The pellet was washed with 500 
μl of 75 % ethanol followed by centrifugation at 12000 g for 5 min at 4 °C. The RNA 
pellet was dried at room temperature and dissolved in 15 μl of RNase free water.  The 
RNA solution was then stored at -80 °C.  The concentration of RNA was determined 
using Nanodrop spectrophotometer ND-1000 (Thermo Scientific, Wilmington, DE). 
Quantitative RT-PCR 
Total RNA was reverse-transcribed using SuperScriptTM II Reverse Transcriptase (Life 
Technologies) with random primer per manufacturer’s instruction.  Quantitative PCR 
was then performed with 1:5 dilution of cDNA on an Applied Biosystems HT7900 
sequence detector.  Primer sets for bovine Timp1 (forward: CAG AAC CGC AGT GAG 
GAG TTT, reverse: GAT GTG CAG GTG CCC ATT C), and U6 (forward: CTC GCT 
TCG GCA GCA CA, reverse: AAC GCT TCA CGA ATT TGC GT) were designed using 
Primer Express 3.0 software (Applied Biosystems).  Samples were run in triplicate, and 
the ΔCt method was used to calculate the relative expression between the samples after 
normalization with U6.  The presence of a single dissociation curve confirmed the 
amplification of a single transcript and lack of primer dimers. 
Statistical Analysis  
All of the quantitative experiments were repeated at least with three biological replicates 
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and were analyzed by one-way ANOVA with Newman-Kuels multiple comparison test 
was performed using GraphPad Prism version 5.00 for Windows, GraphPad Software, 












XI. Chapter VI: Conclusion 
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Since the first study showing the presence of EVs in ovarian follicular fluid in 2012, 
several additional studies were completed that focused on understanding the microRNA 
carried in the follicular EVs.  The potential functions of these specific EVs were 
predicted, but there is still a lack of knowledge on the role of EVs in ovarian follicle 
physiology.  In the studies presented in my dissertation, I have provided evidence that 
follicular EVs can induce cumulus expansion and granulosa cell proliferation, and these 
functions are dependent on the size of follicles where EVs are collected.  These studies 
were conducted during the later stages of folliculogenesis in which there is an antrum 
filled with follicular fluid.  We first characterized follicular EVs from antral follicles of 
different sizes (representing different stages of follicle growth) with regard to their 
physical features as well as their contained cargos (protein and small RNA).  The 
functions of EVs were tested in vitro using cultured granulosa cells and an ex vivo 
cumulus-oocyte-complex expansion assay.  
In my initial experiments, I observed that follicular EVs have a typical lipid bi-layer 
structure or a cup-shape morphology under electronic microscopy (EM) depending on the 
preparation methodology, and a standard size distribution between 50 to 200 nm 
observed by EM or nanosight.  When the comparison was made across different sizes of 
follicles, follicular EVs carry different microRNA contents and are functionally relevant 
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to the physiological state of the follicles isolated from based on bioinformatics prediction.  
For example, miR-204 has been addressed as a cell proliferation inhibitor in several cell 
types (Shi, Huang et al. 2015, Wu, Pan et al. 2015, Wu, Zeng et al. 2015, Wu, Wang et al. 
2015, Xia, Liu et al. 2015, Yin, Liang et al. 2015), and it presented at a higher level in 
larger follicles.  Interestingly, the level of one EV marker, CD81, decreased with the 
growth of follicles while the level of the other marker, β-actin, remained relatively 
unchanged, which brings out the possibility of the existence of different groups of EVs in 
the follicular fluid.  Whether different populations of EVs carry out different functions 
or whether the ovarian cells (granulosa cell, cumulus cell, and oocyte) are able to use 
them differentially according to the physiological condition still needs further 
investigation.     
We first tested the function of EVs on cumulus-oocyte-complex.  EVs showed the 
ability to support cumulus expansion through induction of Ptgs2, Ptx3, and Tnfaip6, 
expression, all of which are known to be critical for the expansion process.  
Interestingly, while both EVs from small and large antral follicles were able to induce the 
expansion, only EVs from small follicles caused the normal increase in expression of 
these genes.  This is an interesting yet perplexing problem.  One possibility is that the 
increasing diameter of cumulus-oocyte-complex that occurs after EV exposure is not a 
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typical cumulus expansion but an effect of cell proliferation or migration.  Another 
possibility is that EVs provide some but not all of the required components for normal 
expansion.    Because cumulus expansion is an event that happens right before 
ovulation we logically, expected EVs from large follicles to have the major effect on 
cumulus expansion, compared to those from small follicles.  Our results showed the 
opposite response.  Therefore, it again raises the idea that there are populations of EVs 
in the follicular fluid and they may be taken up by the cells differentially throughout 
follicular growth.  A possible explanation could be that EVs in favor of cumulus 
expansion are taken up by cumulus cells before the follicles reach a large size and then 
either a suppressive mechanism prevents the expansion in the early stage or another 
signal (maturation) is required to initiate the process.       
During follicular growth, the size of the follicle increases dramatically due to 
pronounced cell proliferation and antrum formation.  The level of cell proliferation 
remains high during the growth of the follicle and slows down approaching ovulation.  
We have shown that EVs are able to increase granulosa cell proliferation and the activity 
of the EVs is follicle size dependent, with EVs from small follicles inducing high levels 
of proliferation while EVs from large follicles do not.  In order to understand the 
cellular pathways that EVs stimulate cellular proliferation through, an antibody-based 
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array was applied to the cell lysate after treating the granulosa cells with EVs from small 
antral follicles.  Proteins that showed a differential expression were subjects for 
bioinformatics analysis, and the results pointed to several signaling pathways including 
ErbB and src signalings.  Treatment of granulosa cells with inhibitors against the kinase 
activities of src and JNK, a downstream molecule of ErbB, abolished the effect of EVs on 
inducing cell proliferation.  Whether EVs induced cell proliferation directly or indirectly 
through these pathways, and what molecules associated with EVs are responsible for the 
effect still need more work.  One of the experiments that can be done next will be 
applying siRNA against these kinases and observing whether this influences the EV-
induced granulosa cell proliferation. 
The functional effects of EVs are likely to be determined by the cargos associated 
with them or by their interaction with recipient cells.  We observed that EVs from 
different sizes of follicles exhibited different activities on inducing granulosa cells.  
Therefore, we tested if these EVs are different in terms of the interaction with the 
granulosa cells.  Interestingly, we found that EVs from small antral follicles, which 
highly induced granulosa cell proliferation, were also more accessible for being taken up 
by the granulosa cells.  Regulated uptake of extracellular materials usually requires the 
involvement of cell surface proteins and it would be very intriguing if the follicular EVs 
195 
 
can serve as a model for the study of EV uptake.  A follow up experiment to compare 
the protein composition of EVs from small and large follicles will help to identify 
candidate proteins important for EV uptake.  
In summary, my studies provide the first comprehensive analysis of follicular EVs 
through folliculogenesis.  I collected follicular EVs from different sized antral follicles 
and characterized their containing miRNA.  I also characterized their functional effects 
on inducing cumulus expansion and granulosa cell proliferation.  My results indicate 
that follicular EVs have effects on both cumulus-oocyte-complex expansion and 
granulosa cell proliferation indicating another possible layer of cell-to-cell 
communication system that has not been previously considered within the ovarian 
follicle.  Our studies also provide an improved protocol for collecting EVs, based on the 
“gold standard” ultracentrifugation method combined with a size exclusion method.  
Moreover, the observation that follicular EVs from different sized follicles have 
differential potential for being taken up by granulosa cells provides a unique model for 
studying molecules important for EV uptake.  In conclusion, this dissertation describes 
several physiologic roles for follicular EVs within the ovarian follicle and also 
demonstrates that the ovarian follicle has great potential for furthering our understanding 
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